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ABSTRACT
HIF-1, a basic helix-loop-helix transcription factor, is the critical mediator 
of oxygen-dependent gene expression in most organisms. Well-characterized in 
mammals, HIF-1 is a heterodimer composed of an alpha and beta subunit, 
although its biological activity is determined by the activity of the HIF-1 a subunit. 
Following exposure to hypoxic conditions, HIF-1 a protein is stabilized and 
translocates to the nucleus, where it activates the transcription of a number of 
hypoxia-inducible genes. While the post-translational control of HIF-1 a has been 
well characterized, much less is known about its transcriptional regulation. In the 
present study, we set out to determine if transcriptional regulation of HIF-1a is a 
general feature of vertebrate development, and the degree to which HIF-1 a 
promoter structure and regulation are conserved in a non-mammalian species. 
To this end, we have cloned the upstream regulatory regions of the HIF-1 a gene 
in Xenopus iaevis and analyzed the gene’s embryonic expression pattern. 
Using transgenic techniques, we present the first in vivo characterization of a 
vertebrate HIF-1 a promoter. These experiments, combined with in vitro 
transfection and the analysis of HIF-1 a alleles, have allowed us to identify a short 
region of the promoter sufficient to drive normal HIF-1 a expression during 
Xenopus development.
CLONING AND FUNCTIONAL CHARACTERIZATION OF THE UPSTREAM 
REGIONS OF HYPOXIA-INDUCIBLE FACTOR 1a IN XENOPUS LAEVIS
2INTRODUCTION
As the final electron acceptor in the electron transport chain, oxygen is 
essential for the cellular production of ATP in aerobic environments. 
Consequently, few organisms in the animal kingdom can survive prolonged 
periods of anoxia. This need has led necessitated highly sensitive and regulated 
mechanisms to maintain oxygen homeostasis (reviewed in Hochachka and Lutz, 
2001). A central mediator of oxygen-dependent gene expression is the HIF-1 
complex. Well-characterized in mammals, HIF-1 is a heterodimer composed of 
an alpha and beta subunit, although its biological activity is determined by the 
activity of the HIF-1a subunit (Jiang et al., 1996; Jiang et al., 1997). Under 
normoxic conditions, HIF-1 a protein is ubiquinated and rapidly degraded by the 
proteasome. However, following exposure to hypoxia, HIF-1 a is stabilized and 
translocates to the nucleus, where it activates the transcription of a number of 
hypoxia-inducible genes by binding to a response element present in the 
upstream regulatory regions.
While the post-translational control of HIF-1 a is well understood, 
particularly in mammals, much less is known regarding the relative importance of 
the transcriptional regulation of HIF-1 a. Several studies have reported no 
significant changes in HIF-1 a mRNA levels in response to hypoxia either in vitro 
in mammalian and fish cell lines (Wenger et al., 1997a; Wenger etal., 1997b;
3Soitamo et al., 2001) or in vivo in mouse (Stroka et al., 2001). However, other 
reports demonstrated that while HIF-1 a mRNA is constitutively expressed in cell 
culture, it is inducible to higher levels under low oxygen conditions (Wang et al., 
1995). An increasing number of studies have consistently found that HIF-1 a 
mRNA levels are upregulated in response to hypoxia; this has been 
demonstrated in the heart of chick embryo (Catron et al., 2001), ferret lung (Yu et 
al., 1998), and neonatal rat heart (Nguyen and Claycomb, 1999). Moreover, 
levels of human HIF-1a mRNA are increased in an early response to cardiac 
ischemia (Lee et al., 2000).
Although hypoxia is often associated with patho-physiologic conditions 
(reviewed in Semenza, 2000), it is also a natural aspect of development to which 
embryos must adapt, suggesting that HIF-1a expression is tightly regulated 
during development (Chen et al., 1999). Its critical role is illustrated by a 
homozygous null deletion of the HIF-1 a gene in mouse; resulting embryos are 
developmentally arrested by embryonic day 8, exhibiting marked cardiovascular 
malformation and a failure of the neural tube to close (Iyer et al., 1998). The 
hypoxic conditions present during the latter part of gestation in developing rat 
brain have been demonstrated to induce a localized increase in HIF-1 a 
transcripts (Royer et al., 2000). Furthermore, in situ hybridization data show 
spatial regulation of HIF-1 a mRNA in the mouse embryo, with the highest levels 
present in the brain, heart, and kidney (Jain et al., 1998). Work in the chick 
embryo has shown increased HIF-1 a expression in areas analogous to those 
identified in embryonic mouse (Takahashi et al. 2001). There is also evidence
4for temporal regulation, as HlF-1a mRNA expression has been shown to be 
relatively high in early mouse and human fetal stages and decrease as gestation 
progresses (Madan et al., 2002).
The majority of work on the regulation of the HIF-1 a system has been in 
mammalian systems, and although the mouse and human promoter regions have 
been characterized, the in vivo analysis of any vertebrate HIF-1 a promoter has 
yet to be performed. Given the key role of hypoxia in embryogenesis and the 
wide scope of action that HIF-1 a has in the cell (reviewed in Semenza, 2002), we 
wish to determine if control of HIF-1 a at the transcriptional level is a general 
feature of its regulation during vertebrate development, and the degree to which 
HIF-1 a promoter structure and regulation may be conserved in a non-mammalian 
species. In order to address these questions, we have cloned the upstream 
regulatory regions of HIF-1 a in the amphibian Xenopus laevis and characterized 
the gene’s developmental expression pattern. The accessibility of large numbers 
of eggs, the ease of embryonic manipulation, and the availability of transgenesis 
in Xenopus makes the frog an excellent model for examining HIF-1 a gene 
expression in vivo (Kroll and Amaya, 1996; Kroll and Kirschner, 1999). In the 
present study, we have generated transgenic Xenopus embryos in order to 
analyze the expression patterns of GFP reporter constructs driven by truncated 
portions of xHIF-1a 5’-flanking sequence. These experiments, coupled with in 
vitro transfection of these constructs and the sequence analysis of two xHIF-1a 
alleles, have allowed us to identify a short conserved region of the promoter 
sufficient for normal expression of xHIF-1a during Xenopus development.
5EXPERIMENTAL PROCEDURES
Cloning of Xenopus HIF-1acDNA
Clones containing the xHIF-1a cDNA were isolated by low stringency 
screening (Sambrook and Russell, 2001) of a Xenopus liver cDNA library using a 
radiolabeled probe consisting of the mouse EPAS1 cDNA sequence (GenBank 
accession NM_010137, a gift of S. McKnight). Phage DNA was isolated from 
positive clones using standard techniques (Sambrook and Russell, 2001). The 
xHIF-1 a cDNA sequence has been deposited in GenBank under the accession 
number AY189821.
Isolation of HIF-1 a Promoter Alleles and Sequencing
Genomic clones containing the xHIF-1a upstream region were isolated by 
low stringency screening (Sambrook and Russell, 2001) of a Xenopus genomic 
library (Clontech) with a 158 bp radiolabeled probe from exon 1 of the xHIF-1a 
cDNA (bases 128-285). Screening of approximately 2.5 x 105 phage plaques 
produced five positive clones whose DNA was subsequently isolated using 
standard techniques. Phage DNA from the initial clone was digested with Sacl to 
excise the entire insert from X EMBL3 SP6/T7 and cloned into pBluescriptSK+ 
(Stratagene). This clone was digested with various restriction enzymes and 
Southern blot analysis was performed to identify and subsequently subclone 
xHIF-1a exon 1 and upstream regions. Hybridizing fragments were sequenced
using the SequiTherm EXCEL II kit (Epicentre Technologies) on a LiCor 4200 
sequencer. Sequence from additional clones was obtained using LiCor Dye800 
terminator sequencing with one of the following primers: 5’- 
CTGGAGTTCTAGGAGAAGCTTTGC or 5’- 
GAACAT GGTGCAAAGCGTGCAACTTC.
Inserts from four remaining positive phage isolates were excised with Sacl 
and cloned into pBluescriptSK+. Both strands of each clone were sequenced 
using dye terminator sequencing with specific primers designed using the initial 
phage isolate HIF-1 a 5’ sequence. The overlapping sequences were aligned 
using the Sequencher software package (GeneCodes) to obtain 3 kb of the 5’ 
flanking sequences for each genomic clone. Subsequent sequence analysis and 
manipulations were performed using the Vector NTI (Informax) and OMIGA 
(Oxford Molecular) software packages. The above sequences have been 
deposited in GenBank under the accession numbers AY262064-AY262068.
In situ Hybridization
Probes were transcribed from the pxHIFI plasmid, containing the 1467 bp 
partial xHIF-1a cDNA in pBluescriptSK+, and labeled with digoxigenin-UTP. To 
generate the antisense probe, pxHIFI was linearized with BamHI and transcribed 
with T3 RNA polymerase; the sense probe was generated by linearizing pxHIFI 
with Hindi 11 and transcribing with T7 RNA polymerase. Whole mount in situ 
hybridization was performed with staged embryos (Nieuwkoop and Faber, 1967) 
as described in Sive et al. (2000) with the following minor modifications: embryos
were fixed in MEMFA (100 mM MOPS, pH 7.4, 2 mM EGTA, 1 mM MgS04, and 
3.7% formaldehyde) for one hour at room temperature then successively washed 
for five minutes in 100% ethanol, 75% ethanol, 25% ethanol/75%PTw (10 mM 
phosphate buffer, pH 7.4, 150 mM NaCI and 0.1% Tween 20), and 100% PTw; 
following treatment with acetic anhydride, the embryos were rinsed twice for 5 
minutes in PTw; to visualize antibody bound to probe RNA, embryos were 
incubated with 1 ml AP buffer (100mM Tris, pH 9.5, 50mM MgCI2, 100mM NaCI, 
0.1% Tween 20, 2mM levamisol) containing 4.5 pi nitro blue tetrazolium (50 
mg/ml) and 3.5 pi 5-bromo-4-chloro-3-indolyl phosphate (50 mg/ml) at room 
temperature until staining became apparent. The embryos were then embedded 
in paraffin, cut into 10 pm sections, and mounted onto microscope slides for 
visualization by light microscopy.
Construction of GFP Reporter Plasmids
Oligonucleotide primers (Genelink) were used to create four different GFP 
constructs through amplification of specific xHIF-1a 5’ flanking regions from our 
original genomic clone. Except where noted, fresh PCR product was cloned into 
pCRII vector (Invitrogen) following the manufacturer’s instructions and then 
excised using EcoRI for subsequent cloning into pEGFP-1 vector (Clontech).
Dye terminator sequencing as described above was used to confirm the identity 
and orientation of all constructs. Abbreviations in the construct names are based 
on the sequence position relative to the xHIF-1a transcriptional initiation site, as 
determined by ribonuclease protection analysis.
HIF(-1658)GFP was made by amplifying a 2492bp fragment from the 
initial phage DNA isolate using the primers 5’-CCCCCAAGCAGCCTAACAACAG 
and 5’-GCCAAACGAGTGGGGGAGGGAC. Following cloning into pCRII, 
digestion with EcoRI resulted in a deletion of the 5’ end, yielding a final 1958 bp 
(-1658/+302) fragment that was ligated into pEGFP-1.
HIF(-508)GFP was constructed by amplifying a fragment that extended 
808 bp (-508/+302) upstream of the xHIF-1a translational start site using the 
primers 5’-CTGGAGTTCTAGGAGAAGCTTTGC and 5- 
GCCAAACGAGTGGGGGAGGGAC.
HIF(-181)GFP was produced by digesting the xHIF-1a genomic clone with 
SnaBI and Hindlll to excise 1.5 kb from the 5’ end of the insert. The remaining 
overhangs were filled in with Klenow DNA polymerase and the blunt-ends ligated 
together with T4 DNA ligase, resulting in a 481 bp (-181/+302) insert in pEGFP-1.
HIF(UTR)GFP was constructed by amplifying 279 bp (+23/+302) of the 
xHIF-1a 5’ UTR from the genomic clone using the primers 5’- 
TTTTGTTTGCGTTGAATCAGGAGT and 5’-GCCAAACGAGTGGGGGAGGGAC.
Ribonuclease Protection Assay
Two probes from different regions of Xenopus laevis HIF-1 a were 
employed. The first of these, HIFexI, consists of the region immediately 
upstream of the xHIF-1a translational start site. pHIFexI was constructed by 
PCR amplification of an 808 bp fragment from the genomic clone with the 
primers 5’-CTGGAGTTCTAGGAGAAGCTTTGC and 5’-
GCCAAACGAGTGGGGGAGGGAC . This fragment was cloned into 
pBluescriptSK+, linearized with BamHI, and transcribed with T3 RNA polymerase 
to produce an antisense probe. Linearizing pHIFexI with Hindlll and transcribing 
with T7 RNA polymerase produced a corresponding sense probe. The second 
xHIF-1 a specific probe, HIFex5-6, was constructed from a 206bp fragment that 
was amplified from exon 5 and 6 of the xHIF-1a cDNA using the primers 5’- 
GAACAAATCACAGAGCGAAGTTTC and 5-
GAGGAATTGGTTCACAGATTACAACC. The resulting fragment was cloned into 
pCRII in both orientations, linearized with BamFII, and transcribed with T7 RNA 
polymerase to produce sense and antisense probes.
Xenopus elongation factor-1 a (EF-1a) or cytoskeletal actin served as an 
internal control for all assays (Gurdon et al., 1985; Kreig et al., 1989). Because 
EF-1a is developmentally regulated and not detectable before stage 8, the less 
abundant cytoskeletal actin gene served as the normalization control for assays 
where band intensities were quantitated. Both probes were re-subcloned into 
pBluescriptSK+. A 1782 bp fragment of pSp64 EF-1a/GS17 was excised with 
Pstl, cloned into pBluescriptSK+, linearized with Ncol, and transcribed with T7 
RNA polymerase to produce a 185bp EF-1a probe. A 900bp Pstl-EcoRI 
cytoskeletal actin fragment was excised from pSpp-1, cloned into 
pBluescriptSK+, linearized with EcoRI, and transcribed with T7 RNA polymerase. 
These two antisense probes detected protected fragments that were 119bp and 
85bp in size, respectively.
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Total RNA was isolated from staged Xenopus embryos using the RNeasy 
kit (Qiagen) according to the manufacturer’s instructions. Ribonuclease 
protection assay (RPA) was performed on approximately 20 jug of total RNA 
using the HIFexI or HIFex5-6 probe and an internal control using standard 
methods (Sambrook and Russell, 2001) with the following modifications: 
transcription of linearized templates (1-2 |^g) was carried out at 37°C for 45 
minutes in a final volume of 20 jul containing 40 mM Tris (pH 8.0), 8 mM MgCb, 2 
mM spermidine, 50 mM NaCI, 10 mM DTT, 500 pM r(GAC)TP, 12 juM rUTP, 1.2 
U/nl Rnasin, 30 ^Ci of [32P]rUTP (800 Ci/mmol, NEN), and 50 U RNA 
polymerase; an additional 50 U of RNA polymerase was added and the reactions 
were incubated an additional 45 minutes; hybridizations were performed at 55°C 
overnight (10-16 hr) in a total volume of 20 jJ hybridization mix with 50,000- 
100,000 cpm of probe; samples were treated with RNase and digested at 37°C 
for 30 minutes. Protected fragments were resolved on a 6% polyacrylamide-8M 
urea sequencing gel and visualized by exposing the gel to X-ray film with an 
intensifying screen at -80°C for 1-4 days. The autoradiographs were digitized 
into TIF files and subjected to densitometric analysis using the ImageQuant 5.0 
software package (Amersham Biosciences). Values were imported into Microsoft 
Excel and SigmaPlot (SPSS Science) for numerical analysis and data plotting. 
Background intensities were subtracted from each HIF-1 a protected band and 
normalized to the cytoskeletal actin protected band before comparisons of the 
relative ratios of intensity at each embryonic stage were determined.
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Transgenesis
Transgenic Xenopus laevis embryos expressing the xHIF-1a promoter 
constructs described above were generated using the restriction enzyme 
mediated integration (REMI) method essentially as described by Kroll and Amaya 
(1996). The reaction was prepared by mixing 5 pi of Notl linearized plasmid 
(150-300 ng/jLtl) with 1.0 pi of sperm nuclei (~4 x 105 nuclei). Following 
incubation at room temperature for 5 minutes, 2 pi of 100 mM MgCh, 0.5 pi of a 
1:20 dilution of Notl (1000U/pl), 10 pi of oocyte extract (preheated at 80°C for 8 
minutes then centrifuged at 14,000 x g for 5 minutes), and 15 pi of sperm dilution 
buffer (250 mM sucrose; 75 mM KCI; 0.5 mM spermidine trihydrochloride; 0.2 
mM spermine tetrahydrochloride) were added and incubated at room 
temperature 10 additional minutes. The reaction mix was diluted in sperm 
dilution buffer to a final concentration of 3-5 sperm nuclei per 5 nl, and injected 
into dejellied oocytes at a rate of 5 nl/sec using a syringe pump (AH 55-4154, 
Harvard Apparatus). Normally developing embryos were maintained in 0.1 X 
MMR with gentamycin sulfate (50pg/ml) until stage 33, when they were snap 
frozen in liquid nitrogen or fixed in 1X MEMFA for further analysis.
Identification o f Transgenic Embryos by PCR
To confirm transgene integration in the embryos produced using the REMI 
method, PCR was performed on genomic DNA using GFP specific primers. 
Genomic DNA was isolated from individual embryos according to the method of 
Sive et al. (2001). PCR primers used to amplify GFP were: (forward) 5’-
12
CAAGCTGACCCTGAAGTTCATCTG and (reverse) 5’-
CGGATCTTGAAGTTGACCTTGATC. The reaction mixture for PCR included 10 
mM Tris-HCI, pH 8.3, 50 mM KCI, 1.5mM MgCI2, 0.2 mM each dNTP, 1pM of 
each primer, and 2.5 units of AmpliTaq (PerkinElmer Life Sciences). PCR was 
performed as follows: 5 minutes at 95°C followed by 30 cycles of 94°C for 40s, 
55°C for 1 minute, and 72°C for 1 minute, followed by a final 7 minutes at 72°C. 
PCR results were analyzed on 1.5% agarose gels.
Cell Culture and Transfections
The Xenopus renal epithelial cell line A6 (CCL-102; American Type 
Culture Collection) was maintained in 75% NCTC-109 medium (BioWhittaker,
Inc.) supplemented with 10% (v/v) fetal bovine serum (heat inactivated at 60°C 
for 30 minutes), 100 pg/ml of streptomycin, and 100 U/ml of penicillin, at 26°C in 
humidified 5% C 02. For each experiment, approximately 6 *105 cells were co­
transfected with the GFP construct of interest and pCMVp (BD Biosciences) 
using LipofectAMINE reagent (Invitrogen) according to the manufacturer’s 
instructions. Briefly, 2 pg of DNA was diluted in 250 j l x I  of serum-free medium 
and 14 pi of PLUS reagent (Invitrogen) was added. Following a 15 minute 
incubation at room temperature, 20 pi of LipofectAMINE diluted in 250 pi serum- 
free medium was added to the reaction. This was incubated at room 
temperature for 15 minutes and gently added to cultures in 60 mm dishes 
containing 4 ml made NCTC-109 medium. After 24 hours, the transfection 
medium was replaced with fresh medium and the cells were incubated for an
13
additional 48 hours as above. To assay cultures for GFP activity, each cell 
monolayer was digested with 0.25% trypsin solution and lysed using sonic 
disruption and 50 pi reporter lysis buffer (Promega). Cell lysate fluorescence 
was measured using a VersaFluor fluorometer (Bio-Rad) equipped with GFP 
filters. These values were normalized to p-galactosidase activity as measured 
using the p-galactosidase enzyme assay kit (Promega) according to the 
manufacturer’s protocols. The SuperANOVA software package was used to 
perform ANOVA analysis to test for differences among the six treatment groups. 
Because the variance of pEGFP-C1 was significantly different from other 
treatments, ANOVA was carried out on log-transformed data. Eight a priori 
comparisons (orthogonal contrast comparisons) were performed. The critical 
value for each of the planned comparisons was adjusted to 0.00625 according to 
the method of Bonferroni to give an experiment-wise significance level of p <
0.05.
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RESULTS
Isolation o f Xenopus HIF-1 a Upstream Regions
AxHIF-1 a exon 1 cDNA probe (GenBank accession AY189821) was used 
to screen a X. laevis genomic library at low stringency in order to identify clones 
containing a HIF-1a promoter region. We screened 2.5 x 106 plaques and 
obtained five positive clones. One of these clones was further analyzed by 
Southern blot using the 5’ xHIF-1a cDNA probe to localize the approximate 
position of upstream regulatory regions. A 4554 bp EcoRV fragment and a 2386 
Sacll fragment that hybridized with the probe were subcloned into 
pBluescriptSK+ and sequenced using both primer-labeled and dye terminator 
methods. Subsequent sequence analysis revealed that the sequence contained 
the 5’ flanking sequence, first exon, and 2020 bases of the first intron of HIF-1 a.
Sequencing o f additional HIF-1 a promoter alleles
Recombinant phage DNA from the four additional positive clones was 
subjected to Southern blot analysis using the 5’ xHIF-1a cDNA probe to confirm 
the inserts contained HIF-1 a. Both strands of each clone were sequenced using 
oligonucleotide primers designed against the original EcoRV promoter clone to 
obtain approximately 3 kb of upstream sequence. A multiple alignment of these 
sequences revealed two distinct alleles with clearly divergent nucleotide 
sequences (Fig. 1). xgHIF1a-1, xgHIF1a-2, xgHIF1a-3, and xgHIF1a-5, together
15
Fig 1. Schematic represention of nucleotide sequence polymorphisms of xHIF-1a 
promoter alleles. A , the horizontal line represents the sequence of xgHIF1a-1 (GenBank 
accession AY262068), used in transgenic experiments. Vertical dashes signify SNPs between 
this strand and xgHIF1a-2 (GenBank accession AY262066), xgHIF1a-3 (GenBank accession 
AY262065), and xgHIF1a-5 (GenBank accession AY262067). Single deletions and insertions are 
symbolized by triangles and diamonds, respectively. A small number above or below the symbols 
indicates the number of nucleotides inserted or deleted if more than one; +1 indicates the site of 
transcriptional initiation. B, the horizontal line represents the sequence of the more divergent 
xgHIF1a-4 (GenBank accession AY262064) allele. Symbols represent the differences between 
this allele and one other isolate, xgHIF1a-1.
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share over 99% identity, with 10 single nucleotide polymorphisms (SNPs), 11 
deletions, and 1 insertion between them. The sequence of xgHIF1a-4, the 
remaining clone, has only 95% identity with the other promoter sequences and 
represents a more divergent xHIF-1a allele; when compared to xgHIF1a-1 alone, 
xgHIF1a-4 contains 76 SNPs, 8 insertions, and 5 deletions.
RPA analysis
Ribonuclease protection assay was utilized to identify the xHIF-1a 
transcriptional start site and to determine steady state mRNA levels throughout 
development. An antisense probe consisting of an 808bp xHIF-1 a fragment 
located immediately upstream of the translational start site was hybridized with 
total RNA isolated from embryos at different developmental stages. This 
analysis revealed two distinct protected fragments, HIFex1(300) and 
HIFex1(365), that mapped to approximately 300 bp and 365 bp upstream of the 
translational start site and displayed developmental regulation (Fig. 2A). In 
addition, a 206 bp probe spanning exons 5 and 6 of the xHIF-1a gene was 
employed as a control; this probe protected a fragment (HIFex5-6) of the 
predicted size in all developmental stages assayed and also showed 
developmental regulation (Fig. 2B). The relative expression levels of the 
protected fragments HIFex5-6 and the HIFex1(300) are similar in unfertilized 
eggs and follow the same trend throughout the developmental stages assayed.
A sharp increase in expression is observed which peaks around mid-gastrulation 
(stage 12), with levels two to three times those present before the midblastula
17
Fig 2. Ribonuclease protection analysis of xHIF-1a transcriptional initiation site. A, the 808
bp HIFexI probe was hybridized with 20 fig of total RNA from embryos of different developmental 
stages. Two protected fragments were resolved, of approximately 365 bp (upper) and 300 bp 
(lower) representing putative transcriptional initiation sites. B, the HIFex5-6 probe protected a 
fragment of the expected size (206 bp) in all stages assayed. In both cases, a Xenopus 
cytoskeletal actin antisense probe was used to correct for procedural errors. The protected 
fragments obtained from both HIFexI and HIFex5-6 were replicated in at least five independent 
experiments. Identical protected fragments were observed using Xenopus elongation factor-1 
alpha (EF-1a) as an internal control probe. Numbers above each lane represent the 
developmental stages assayed: ue = unfeftilized egg; 3/4 = early cleavage; 10 = early 
gastrulation; 12 = mid-gastrulation; 20 = early tailbud; 25 = late tailbud; 33 = hatching; 41, 43 = 
swimming tadpole.
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Fig 3. Developmental profile of xHIF-1a expression. A, graph representing the relative 
expression levels of the three protected fragments observed in the RPAs (parentheses in legend 
indicate the size in base pairs of the protected band). The levels of HIFex5-6 and HIFexI (300) 
increase during gastrulation and are followed by a rapid decline to steady state levels post stage 
23. HIFexI(365) follows a similar trend, increasing at gastrulation before dropping to 
undetectable levels by early tailbud stage. Densitometric analysis was used to normalize xHIF- 
1a to cytoskeletal actin expression (see Experimental Procedures). Data points for each probe 
represent the mean values obtained from two independent experiments. B, graph showing the 
ratio of the two protected fragments obtained with the HIFexI probe. The 365 bp fragment is 
found exclusively in early embryonic stages before rapidly diminishing and becoming 
undetectable by stage 23. Similar trends in xHIF-1a expression were observed using EF-1a as a 
normalization control.
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transition (Fig. 3A). This increase is followed by a rapid decline over neurulation 
(stage 13-20) to a steady level by early tailbud (stage 23). In contrast, the 
H IFexI(365) protected fragment shows a more modest rise during gastrulation 
followed by a dramatic drop in expression similar to that observed for the two 
other fragments (Fig. 3A). However, by stage 23 (early tailbud stage), signal 
from the HIFexI (365) fragment falls to an undetectable level. The difference in 
regulation is particularly evident when comparing the ratio of the HIFexI (365) 
protected fragment to the HIFexI (300) fragment over time (Fig 3B).
In situ hybridization analysis
The spatial expression pattern of xHIF-1a was examined by whole-mount 
in situ hybridization of hatching (stage 33) Xenopus embryos using a digoxigenin- 
labeled antisense RNA probe consisting of a 1467 bp xHIF-1a cDNA fragment 
(Fig. 4). The embryos hybridized with this probe consistently demonstrated a 
stronger signal than negative control embryos processed in parallel using a 
complementary sense RNA probe (Fig. 4, A and B). xHIF-1a is expressed 
ubiquitously at low levels with significantly elevated levels of expression in the 
head and developing nervous system, as well as in the somites (Fig. 4A). To 
confirm this expression pattern, embryos hybridized with the antisense probe and 
their sense counterparts were subjected to histological analysis. A transverse 
section at the level of the hindbrain shows increased expression in the nervous 
system, otic vesicles, and somites (Fig. 4, C and D). More posterior sections
20
Fig 4. Spatial analysis of endogenous xHIF-1a expression in the Xenopus embryo. A,
representative whole mount in situ hybridization of a stage 35 embryo using a digoxigenin-labeled 
xHIF-1 a antisense probe showing a ubiquitous expression pattern. Elevated expression is also 
seen in the head, somitic tissue, and developing nervous system when compared to stage 35 
embryos hybridized with a complementary sense probe (B). The observed expression pattern 
was confirmed through histological analysis of embryos hybridized with either the xHIF-1a 
antisense (C, E) or sense (D, F) probe. Scale bars = 1 mm (A and B) or 0.5 mm (C, D, E, F). 
NO, notochord; NT, neural tube; OV, otic vesicle; SO, somite; arrowheads indicate somitic tissue; 
an asterisk also indicates the otic vesicle.
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show xHIF-1a to be expressed at high levels throughout the neural tube and 
somitic tissue (Fig. 4, E and F).
In vivo functional characterization of HIF-1 a regulatory regions
To determine the upstream elements required for proper expression of 
HIF-1 a, we designed a series of GFP constructs in which the promoter region 
was progressively deleted from the 5’ end (Fig. 5). Using the REMI technique 
(Kroll and Amaya, 1996), these constructs were inserted into the genome of 
Xenopus embryos and the spatial pattern of GFP expression was visualized 
using fluorescence microscopy. For this analysis, only those embryos that were 
of normal appearance or those exhibiting minor morphological defects were 
scored. Following observation, PCR was used to confirm integration of the 
transgene in a total of 37 embryos designated as positive or negative for visual 
fluorescence. Of this number, 38% expressed GFP at clear visual levels and 
tested positive for transgene integration. Forty-six percent of the embryos were 
negative for fluorescence, but did show GFP integration. The remaining 16% 
were not fluorescent and did not show evidence of GFP integration.
Experiments using HIF(-1658)GFP, containing a fragment of the xHIF-1a 
promoter extending 1958 bp immediately upstream of the translational start site, 
produced a fluorescence pattern matching endogenous xHIF-1a RNA expression 
in 49% of developing embryos (n=49) (Fig. 6A). Similar to the pattern detected 
with in situ hybridization, a diffuse fluorescence is seen throughout the embryo 
when compared to GFP-negative controls. In addition, an increased GFP signal
22
Fig 5. Summary of 5’ upstream region analysis using xHIF-1a GFP constructs in 
transgenic embryos. The upstream regions of xHIF-1a in each construct are represented by a 
line. The number indicated in the parentheses of each construct name corresponds to the 
position of the first base in the construct relative to the xHIF-1a transcriptional initiation site (+1). 
White boxes show the 5’ untranslated region, and a shaded box represents the open frame GFP 
coding sequence. Promoterless pEGFP-1 was used as a negative control. To the right, bars 
indicate the percentage of positive embryos (i.e. individuals with HIF-1a specific signals out of all 
embryos scored) for each construct. Numbers next to the percentages indicate the total number 
of transgenic embryos scored for each construct.
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Fig 6. xHIF-1a upstream sequences direct tissue specific expression of GFP in transgenic 
Xenopus embryos. A representative HIF(-1658)GFP transgenic embryo (A) shows elevated 
levels of GFP expression in the head and eye, neural tube, and somitic tissue when compared to 
negative control embryos (D) containing a promoterless pEGFP-1 transgene. HIF(-508)GFP and 
HIF(-181)GFP transgenic embryos (B and C) show a GFP expression pattern identical to the 
construct containing 2 kb of upstream sequence. E, a representative HIF(UTR)GFP transgenic 
embryo showing the less uniform pattern of GFP expression obtained using this construct {the 
posterior end of this embryo is out of the plane of focus and hence appears abnormal, though 
fluorescence is present throughout axial structures). F, higher magnification of the anterior end of 
a HIF(-1658)GFP transgenic embryo demonstrates that the neural tube expresses elevated levels 
of GFP despite being unable to be visualized as a distinct structure in whole mount. G and H, 
arrowheads indicate the elevated GFP expression pattern in the neural tube and somitic tissue of 
a HIF(-1658)GFP transgenic (G) compared to the same region in a negative control embryo (H). 
Scale bars = 1 mm (A, B, C, D, E) or 0.5 mm (F, G, H). ey, eye; gu, gut; nt, neural tube; so, 
somite.
__
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is observed in the head and eye region (Fig. 6F) and also extends down the 
length of the neural tube and somitic tissue (Fig. 6G).
To further delineate the upstream regions sufficient to reproduce HIF-1a 
specific expression, we generated transgenics containing two constructs with 
successive deletions from the 5’ end of the promoter. HIF(-508)GFP and 
HIF(-181)GFP were both able to drive GFP expression in a pattern that matched 
endogenous xHIF-1a (Fig. 6B, 6C), although in a smaller percentage of embryos 
(33% (n=36) and 25% (n=67), respectively). The GFP expression patterns 
present in these embryos were indistinguishable from those observed in the 
HIF(-1658)GFP transgenics. An additional construct, HIF(UTR)GFP, contained 
only the 5’ untranslated regions of the xHIF-1a gene. Although its intensity was 
somewhat variable and more mosaic than the previous constructs, this fragment 
was also able to produce a HIF-like GFP expression pattern in 14% of the 49 
embryos scored (Fig. 6E). A negative control construct, consisting of 
promoterless pEGFP-1 plasmid, yielded only 4% of embryos (n=43) showing a 
GFP pattern that resembled endogenous HIF-1oc expression.
In vitro functional analysis o f HIF-1 a regulatory regions
In order to establish the regions of the xHIF-1a promoter required for 
basal transcriptional activity, the Xenopus renal epithelial A6 cell line was 
transfected with each xHIF-1a promoter construct and assayed for GFP activity. 
pEGFP-C1, containing the CMV promoter, and promoterless pEGFP-1 plasmids 
were used as positive and negative controls, respectively. All values were
25
normalized to p-galactosidase activity to provide an internal control for 
transfection efficiency. HIF(-1658)GFP, HIF(-508)GFP, and HIF(-181)GFP were 
all able to drive clearly visible GFP expression in transfected cells (Fig. 7). In 
addition, there was no statistically significant difference in the measured GFP 
fluorescence levels of each in transfected cells. These results suggest that the 
481 bp region flanking the translational start site is sufficient to drive constitutive 
HIF-1 a promoter activity in A6 cells.
26
Fig 7. Transient transfection analysis of the xHIF-1a promoter-GFP constructs in Xenopus 
A6 cells. xHIF-1a promoter-GFP constructs were co-transfected with pCMVp into A6 cells and 
the relative levels of fluorescence measured after 72 hours. All fluorescence values are 
normalized to p-galactosidase activity and expressed as relative fluorescence units (RFU). 
Promoterless pEGFP-1 plasmid was used to control for basal autofluorescence and its RFU value 
was arbitrarily set to 0. pEGFP-C1, containing a CMV promoter, was used as a positive control. 
Values are the means ± standard error from at least three independent trials and are grouped 
together using letters to the right of error bars (a, b, or c). Different letters indicate significant 
differences with an experiment-wise p < 0.01. The same letters indicate values that are not 
statistically significantly different from each other (p > 0.20 in all cases).
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DISCUSSION
In order to investigate the transcriptional regulation of HIF-1a during 
vertebrate development, we report the cloning and functional characterization of 
the Xenopus HIF-1a promoter, the first such investigation in a non-mammalian 
vertebrate species. To date, the only report of a related non-mammalian 
promoter is from the nematode, C. elegans, which has a functional homologue 
76% similar to human HIF-1a (Jiang et al., 2001). An alignment of the 2 kb 
upstream of the C. elegans hif-1 gene shows no significant similarity to any 
mammalian or Xenopus HIF-1 a promoter sequence. The previously isolated 
mouse and human HIF-1 a promoters show 70% nucleotide identity over their 5’- 
flanking and untranslated regions (Iyer et al., 1998; Luo et al., 1997). However, a 
comparison of the Xenopus HIF-1a promoter to the mouse and human promoters 
reveals no significant alignment (40% and 43%, respectively) over the 700 bp 
region immediately 5’ to the translational start site of the gene. This lack of 
sequence similarity is consistent with previous reports that have demonstrated 
considerable divergence between the Xenopus rhodopsin and C/EPB promoters 
and those of other species (Batni et al., 1996; Kockar et al., 2001; Foka et al., 
2001). Yet all three HIF-1 a promoters do share certain characteristics; all lack a 
TATA box and have a transcriptional initiation site located approximately 300 bp 
upstream of translational start. Moreover, a 14 bp alignment of the bases to 
either side of the three species’ transcriptional initiation sites reveals a striking
28
71% identity (Fig. 8). In addition, the region extending ~170 bp upstream of the 
initiation site is GC-enriched in the three promoters (Xenopus 64%; mouse and 
human 79%). All have at least two housekeeping E-box regulatory domains 
present, with the position of one (starting at -417 relative to transcriptional start) 
shared by Xenopus and mouse. Taken together, these results indicate possible 
selection for maintaining specific elements of sequence structure present in 
vertebrate HIF-1 a upstream regions.
Sequence comparisons of gene alleles in the pseudotetraploid Xenopus 
can be informative for identifying conserved promoter elements. Therefore, two 
kilobases of upstream sequence from both strands of five independently isolated 
xHIF-1 a promoter clones was obtained. An alignment of these five sequences 
reveals two distinct alleles that share 95% identity, a level of nucleotide 
divergence that has frequently been reported in other isolated allelic variants of 
Xenopus promoters (Ghanbari et al., 2001; Graf and Kobel, 1991). Xenopus 
Slug promoter alleles have two conserved motifs critical for regulation of the 
gene separated by less conserved regions and interspersed with different 
repetitive sequence (Vallin et al., 2001). Single nucleotide polymorphisms 
(SNPs) account for the majority of sequence divergence in the isolated xHIF-1a 
promoters, though short insertions and deletions are also present. One such five 
base insertion located at -542 (relative to transcriptional start) in xHIF-1a results 
in the creation of a CCAAT-enhancer binding protein-p consensus binding 
sequence. In stark contrast to the distal regions of the Xenopus HIF-1 a alleles, 
the proximal promoter region (-208/+1) in the two alleles shares 100% identity.
29
Fig 8. Comparison of HIF-1a transcriptional initiation sites. A 21 bp alignment centered on 
the transcriptional initiation sites of the mouse, human, and Xenopus HIF-1a promoters. The first 
14 bp of the alignment are 71% identical between the species. Extending the alignment to a total 
of 21 bp maintains 57% identity. The previously reported mouse and human transcriptional 
initiation sites are underlined. An arrow represents the start of transcription in Xenopus as 
determined by RPA analysis.
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This sequence identity is mirrored in the 5’ UTR, which contains only a single 
SNP between the two. This evidence of selective pressure to maintain the 
proximal promoter region suggests its importance in the regulation of HIF-1 a 
transcription.
In order to fully examine the transcriptional regulation of HIF-1 a, we have 
characterized its expression pattern over the course of Xenopus development. A 
dramatic rise in xHIF-1a mRNA levels is seen during gastrulation just prior to the 
development of the nervous system. This finding is consistent with mouse Hif-1 a 
knockouts that show increased mesenchymal cell death leading to a failure of the 
neural tube to close and subsequent embryonic death at E10.5 (Iyer et al., 1998). 
The time interval surrounding gastrulation represents a critical developmental 
period during which highly coordinated cell and tissue movements result in 
extensive rearrangement of the embryo. It has been shown that hypoxic 
conditions during this period in Drosophila result in cell cycle arrest of syncytial 
divisions (DiGregorio et al., 2001). It is also at this time that the control of 
embryonic cellular processes is switched from maternal to zygotic regulation in 
Xenopus (Stack and Newport, 1997). HIF-1 a is also known to be involved in the 
regulation of a number of genes involved in various developmental pathways, 
including transforming growth factor-p3 (Caniggia et al., 2000), insulin-like growth 
factor-2 (Feldser et al., 1999), and vascular endothelial growth factor (Iyer et al., 
1998). While the observed upregulation of xHIF-1a mRNA during gastrulation 
may represent a transient response to a local hypoxic stimulus within the 
embryo, it is also consistent with a programmed developmental rise in
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expression. Further experiments to characterize the degree of hypoxia present 
in developing Xenopus embryos will address the reasons for this increase in 
HIF-1 a expression.
Several variants of HIF-1 a mRNA displaying tissue-specific expression 
profiles in the adult have been reported in mouse, rat, and human (Chun et al., 
2002; Wenger et al., 1997; Luo et al., 1997; Drutel et al., 2000; Gothie et al.,
2000). These isoforms are produced through alternative splicing or the use of 
multiple transcriptional initiation sites. In mouse, two distinct promoters produce 
alternate first exons, leading to a constitutive or more restricted expression 
pattern (Wenger et al., 1998). We present evidence for the existence of two 
HIF-1 a RNA species in a non-mammalian organism using ribonuclease 
protection assay. The different expression patterns of the xHIF-1a isoforms over 
the course of development suggests a functional difference between the two, as 
has recently been proposed for another Xenopus gene with both a maternal and 
zygotic form, tumorhead (Wu et al., 2003).
In situ hybridization shows endogenous Xenopus HIF-1a mRNA to be 
ubiquitously present throughout the embryo as has been demonstrated in the 
adult tissues of mouse and human (Wiener et al., 1996; Gradin et al., 1996; Luo 
et al., 1997; Wenger et al., 1998). To date, there have been a number of reports 
that HIF-1 a mRNA levels are differentially regulated during development. In the 
mouse, increased HIF-1 a mRNA levels were found to be present in areas of the 
embryo stained with the hypoxia marker pimonidazole (Lee et al., 2001). In 
addition, chick embryos show marked upregulation of HIF-1 a in tissues
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consistent with the hypoxic areas in developing mouse embryos (Takahashi et 
al., 2001; Etchevers, 2003). Our results demonstrate that HIF-1a is spatially 
regulated within the Xenopus embryo, with increased mRNA levels in the 
developing nervous system and axial tissues following hatching (stage 35). This 
finding is in agreement with reports from developing mouse embryos, in which 
increased HIF-1 a levels are found in the heart, somites, and brain (Lee et al.,
2001).
Transgenic experiments utilizing the REMI technique were used to identify 
regions of the promoter capable of directing correct spatial expression of HIF-1 a 
in developing Xenopus embryos. A limitation of this technique, however, is the 
difficulty of controlling the amount of GFP expression in a given individual due to 
variable copy number and the random location of transgene integration into the 
genome (Liu and Green, 2001). Variability in GFP fluorescence was observed in 
different transgenic individuals both between and among injection batches. As a 
result, accurate quantitation of expression levels was difficult among the embryos 
that tested PCR-positive for transgene integration. This question was addressed 
by transient transfection of Xenopus cell culture to measure the basal promoter 
activity of each GFP construct. We have found that a 181 bp portion of the 
Xenopus promoter is sufficient to drive constitutive in vitro GFP expression.
While there is no statistically significant difference in the expression levels 
produced by HIF(-1658)GFP, HIF(-508)GFP, or HIF(-181)GFP, a rising trend in 
expression is observed as the length of the promoter increases. This data is 
consistent with results in mouse, in which 232 bp of the xHIF-1a promoter
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yielded only slightly less luciferase reporter gene expression than a 1.4 kb 
fragment (Wenger et al., 1998). Similar experiments in a human cell line show 
equivalent levels of luciferase reporter gene expression when driven by a 5 kb 
and 700 bp portion of the xHIF-1a promoter (Iyer et al., 1997).
The findings from mammalian and Xenopus cell culture suggest that 
correct transcriptional control of HIF-1 a can be achieved by a relatively short 
promoter region. In vivo transgenic experiments using deleted xHIF-1a promoter 
GFP constructs strongly support these conclusions by demonstrating that 
HIF(-181)GFP can drive reporter expression in transgenic embryos in an 
endogenous pattern. The notion that HIF-1 a requires a relatively short upstream 
sequence to direct tissue specific expression is further supported by the high 
degree of sequence conservation in the proximal promoter and 5’ untranslated 
regions in two isolated xHIF-1a alleles.
While HIF-like GFP expression patterns were observed with all HIF 
constructs, the HIF(-1658)GFP construct yielded the most normal looking 
embryos that matched the endogenous xHIF-1a pattern. It is possible to 
conclude that this construct contains additional regulatory elements, serving to 
enhance the levels of overall transcription or to confine increased expression to 
specific tissues. Other Xenopus promoters have been shown to have distinct 
modules mediating tissue specific transcription levels (Ryffel and Lingott, 2000; 
Vallin et al., 2001). Alternately, a longer promoter can lead to a general 
enhancement of transcription (Wardle et al., 2002). Interestingly, the 
HIF(UTR)GFP construct was able to drive reporter expression in a low
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percentage of the transgenic embryos and also showed activity in transient 
transfection experiments. Mounting evidence suggests that cis-acting elements 
in untranslated regions can have a significant role in enhancing the transcription 
of some genes. This has been reported in a number of mammalian studies, 
including the human hematopoietic prostaglandin D synthase gene, in which the 
untranslated first exon showed -60% of the activity of the entire -1044/+290 
region (Fujimori et al., 2000; Cheng et al., 2003; Wang et al., 2002; Landry et al., 
2001; Hiroi et al., 2001).
In the present study we set out to characterize the transcriptional 
regulation of HIF-1a during development. To that end, we have isolated and 
functionally characterized the xHIF-1a promoter region in Xenopus laevis. Using 
transgenesis, we have shown that 181 bp of the proximal promoter will drive 
reporter GFP expression in a pattern matching endogenous xHIF-1a mRNA 
expression. Similar results were obtained using in vitro cell culture and we have 
shown this region to be highly conserved between the two Xenopus alleles 
described above. In addition, mRNA levels were found to increase during 
gastrulation, indicating an increased need for HIF-1 a during this time period. 
Utilizing the versatile Xenopus system to study vertebrate gene expression in 
vivo, we have formed a basis for further examining the role that HIF-1 a 
transcriptional regulation plays during embryonic development.
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APPENDIX A
MISCELLANEOUS PLASMID AND PRIMER NOMENCLATURE
HIF-1 a promoter-GFP constructs. These constructs consist of Xenopus HIF-1 a 
upstream regions ligated into pEGFP-1 vector. They were used to investigate the 
transcriptional regulation of HIF-1 a both in vivo with transgenesis and in vitro through 
transient transfection of the A6 cell line.
HIF(-1658)GFP
HIF(-508)GFP
HIF(-181)GFP
HIF(UTR)GFP
Miscellaneous GFP constructs. These plasmids were used as positive and negative 
controls in transgenesis and transient tranfections.
pEGFP-1—promoterless GFP vector from Clontech. 
pEGFP-C1—contains the CMV promoter to drive GFP expression (from 
Clontech).
HIF-1 a genomic promoter clones. These are five independent isolates of HIF-1 a 
upstream regions in pBluescriptSK+ that were sequenced and aligned to locate possible 
promoter alleles.
xgHIF1a-1 (GenBank accession AY262068) 
xgHIF1a-2 (AY262066) 
xgHIF1a-3 (AY262065) 
xgHIF1a-4 (AY262064) 
xgHIF1a-5 (AY262067)
Miscellaneous plasmids.
pxHIFI—This clone contains the 1467 bp xHIF-1a cDNA in pBluescriptSK+ used 
to transcribe in situ hybridization probes. This sequence is deposited in 
GenBank under the accession number AY189821.
pxHIFexI—This clone contains the 808 bp immediately upstream of HIF-1 a 
translational start site in pBluescriptSK+. It was used to transcribe the HIFexI 
RPA probe.
RPA probes.
HIFexI—808 bp radiolabeled RNA probe transcribed from pxHIFexI used in the 
identification of xHIF-1a transcriptional initiation site.
HIFex5-6—206bp radiolabeled RNA probe from a region spanning exons 5 and 6 
of xHIF-1<x.
RPA protected fragments.
HIFex1(300)—300 bp fragment of the HIFexI probe representing a HIF-1a form 
expressed throughout Xenopus embryonic development.
HIFex1(365)—approximately 365 bp fragment of the HIFexI representing an 
alternate HIF-1 a form whose expression drops to undetectable levels following 
gastrulation.
HIFex5-6—206 bp fragment of the HIFex5-6 probe used to quantify HIF-1 a 
expression levels over the course of development.
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TABLE 1 
Summary of oligonucleotide primers employed. An asterisk following base 
numbering indicates positions that refer to xHIF-1a cDNA sequence. Superscript 
a following base numbering indicates positions referring to pEGFP-1.
Name Sequence (5’-3’) Position Function
XHIF4 CTGGAGTTCTAGGAGAAGCTTTGC 1691-1714
dye terminator sequencing of initial 
phage isolate
construction of pGFP-0.8kb 
construction of HIF(R) RPA probe
XHIF5 G AACATGGT G CAAAGCGT G CAACTT C 1825-1800 dye terminator sequencing of initial phage isolate
xHIF7 CCCCCAAGCAGCCTAACAACAG 7-28 construction of pGFP-2.0kbSENSE and A/S
xHiF8 GCCAAACGAGTGGGGGAGGGAC 2498-2477 construction of GFP constructs and RPA probes
XHIF9 TTTT GTTT G CGTT GAAT CAGG AGT 2219-2243 construction of pGFP-UTR
xHIFexlF GTCGGATTAATTGCGTCATAAAAC 128-151* amplification of initial genomic library screening probe
xHIFexIR GGGGGAGGGACGCTCCGAAGCT 285-264*2487-2466
amplification of initial genomic 
library screening probe
xHIFex5 G AACAAAT C ACAG AG C G AAGTTT C 775-799*
construction of HIF200 RPA probe 
control primer for genotyping 
transgenic embryos
xHIFex6 GAGGAATTGGTTCACAGATTACAACC 984-958*
construction of HIF200 RPA probe 
control primer for genotyping 
transgenic embryos
GFP1 CAAGCT GACCCT GAAGTT CAT CT G 219-2423
genotyping of transgenic embryos 
(forward primer)
GFP2 CGGAT CTT GAAGTT GACCTT GAT C 602-6253
genotyping of transgenic embryos 
(reverse primer)
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APPENDIX B 
PRIMARY SEQUENCE DATA
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L O C U S  A Y 1 8 9 8 2 1  1 4 6 7  b p  m R N A  l i n e a r  V R T  2 1 - M A R - 2 0 0 3
D E F I N I T I O N  X e n o p u s  l a e v i s  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  m R N A ,  
P a r t i a l  c d s .
A C C E S S I O N  A Y 1 8 9 8 2 1
V E R S I O N  A Y 1 8  9 8 2 1
K E Y W O R D S
S O U R C E  X e n o p u s  l a e v i s  ( A f r i c a n  c l a w e d  f r o g )
O R G A N I S M  X e n o p u s  l a e v i s
E u k a r y o t a ;  M e t a z o a ;  C h o r d a t a ;  C r a n i a t a ;  V e r t e b r a t a ;  
E u t e l e o s t o m i ;  A m p h i b i a ;  B a t r a c h i a ;  A n u r a ;  M e s o b a t r a c h i a ;  
P i p o i d e a ;  P i p i d a e ;  X e n o p o d i n a e ;  X e n o p u s .
R E F E R E N C E  1  ( b a s e s  1  t o  1 4  6 7 )
A U T H O R S  S i p e ,  C  .  W .  a n d  S a h a , M . S .
T I T L E  C l o n i n g  a n d  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  u p s t r e a m
R e g u l a t o r y  r e g i o n s  o f  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  i n  
X e n o p u s  l a e v i s  
J O U R N A L  U n p u b l i s h e d
R E F E R E N C E  2  ( b a s e s  1  t o  1 4  6 7 )
A U T H O R S  S i p e , C . W .  a n d  S a h a , M . S .
T I T L E  D i r e c t  S u b m i s s i o n
J O U R N A L  S u b m i t t e d  ( 0 3 - D E C - 2 0 0 2 )  B i o l o g y ,  C o l l e g e  o f  W i l l i a m  a n d
M a r y , P . O .  B o x  8 7 9 5 ,  W i l l i a m s b u r g ,  V A  2 3 1 8 5 ,  U S A  
F E A T U R E S  L o c a t i o n / Q u a l i f i e r s
s o u r c e  1 . . 1 4  6 7
/ o r g a n i s m = " X e n o p u s  l a e v i s "
/ d b _ x r e f = " t a x o n : 8  3 5 5 "
/ t i s s u e _ t y p e = " l i v e r "
C D S  < 1 . . > 1 4  6 7
/ n o t e = " H I F - l a "
/ c o d o n _ s t a r t = l
/ p r o d u c t = " h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a "  
/ p r o t e i n _ i d = " A A 0 7 2 7  3 3 "
/ t r a n s l a t i o n = " E R R K E K S R D A A R C R R S K E S E V F Y E L S H E L P L P H N V S  
S H L D K A S I M R L A I S Y L R L R R L L D A G D L D G E T D L D K Q L N C F Y L K A L E G F V L  
V L T E E G D M I Y L S E N V N K C M G L T Q F E L T G H S V F D F T H P C D H E E L R E M L T F R  
N G P A K K G K E Q I T E R S F F L R M K C T V T S R G R T V N I K S A T W K V L H C T G H M R V Y  
D N A N N Q K H C G Y K K P P M K C M V V I C E P I P H P S N I E F P L D S K T F L S R H S L D M K  
F S Y C D E R V T E L V G Y D P D E L L G R S V Y E Y Y H A L D S D H L T K A H H N M F T K G Q V T  
T G Q Y R M L A K K G G Y V W V E T Q A T V I Y N S K N S Q P Q C I V C V N Y V L S E V V E K D L I  
L S L G Q T A C V L I P A E S Q E M K M P E I F T D L S E E N N D E C L F D K L K Q E P E S L T A L  
A P D A G D D I I P L D F S S G D S D K P Y E D V P L Y N D V M L H S T S K K L E S T P V T P L P A  
S E M L K P L R S N V D P A L N R E V V I K M E S N P E Q L E L A F T I P Q P S K P G S L R I S V P  
V R A "
B A S E  C O U N T  4 2 8  a  3 0 9  c  3 5 1  g  3 7 9  t
O R I G I N
1  g a g c g g c g t a  a a g a a a a a t c  a c g t g a t g c t  g c c a g g t g t c  g g a g g a g t a a  g g a g t c g g a g
6 1  g t t t t t t a t g  a a c t a t c t c a  c g a g t t g c c t  c t a c c g c a c a  a t g t c a g c t c  a c a c c t t g a c
1 2 1  a a g g c c t c t a  t c a t g a g a c t  c g c c a t c a g t  t a c c t g c g g t  t g a g a a g g t t  g c t t g a c g c a
1 8 1  g g g g a t t t g g  a t g g t g a g a c  c g a t t t g g a c  a a g c a a c t g a  a t t g t t t c t a  t t t g a a g g c t
2 4 1  c t g g a a g g g t  t t g t c t t g g t  t c t a a c t g a a  g a g g g g g a t a  t g a t t t a t c t  a t c t g a a a a t
3 0 1  g t c a a c a a g t  g t a t g g g c c t  c a c a c a g t t t  g a g c t t a c t g  g a c a c a g t g t  g t t t g a t t t c
3 6 1  a c t c a t c c t t  g c g a t c a t g a  a g a g c t a a g g  g a g a t g c t g a  c t t t c a g a a a  t g g g c c a g c a
4 2 1  a a a a a a g g a a  a a g a a c a a a t  c a c a g a g c g a  a g t t t c t t c c  t t c g t a t g a a  g t g c a c g g t a
4 8 1  a c t a g t c g t g  g g a g a a c a g t  g a a t a t a a a g  t c a g c c a c a t  g g a a g g t a c t  t c a c t g t a c a
5 4 1  g g a c a c a t g c  g t g t a t a t g a  t a a t g c a a a c  a a c c a g a a g c  a t t g t g g c t a  c a a g a a g c c t
6 0 1  c c c a t g a a g t  g c a t g g t t g t  a a t c t g t g a a  c c a a t t c c t c  a t c c a t c a a a  t a t t g a g t t c
6 6 1  c c c t t g g a t a  g c a a g a c c t t  c c t c a g t c g c  c a c a g c c t t g  a c a t g a a g t t  t t c c t a c t g t
7 2 1
7 8 1
8 4 1
9 0 1
9 6 1
1021
1 0 8 1
1 1 4 1
1201
1 2 6 1
1 3 2 1
1 3 8 1
1 4 4 1
/ /
g a t g a a a g g g
t a t g a a t a t t
a c a a a g g g a c
t g g g t t g a a a
g t t t g t g t a a
c a g a c a g c a t
a c a g a c c t g a
g a a t c t c t t a
t c a g g t g a t t
t c t a c c a g t a
a a g c c t t t g c
t c a a a t c c a g
c t t c g g a t a t
t a a c t g a a t t
a t c a t g c c t t
a g g t g a c t a c
c a c a a g c c a c
a c t a t g t a c t
g t g t t t t g a t
g c g a g g a g a a
c a g c t c t t g c
c t g a c a a g c c
a g a a a c t g g a
g a a g c a a t g t
a a c a a c t t g a
c g g t t c c a g t
a g t a g g a t a t  
g g a c t c t g a t  
t g g g c a g t a c  
t g t t a t a t a c  
c a g t g a g g t g  
t c c a g c g g a a  
c a a t g a c g a g  
g c c c g a t g c t  
a t a t g a a g a t  
a a g t a c a c c c  
t g a c c c t g c a  
g c t g g c g t t c  
c a g a g c t
g a c c c a g a t g  
c a t t t g a c c a  
a g a a t g c t t g  
a a t t c t a a g a  
g t g g a g a a a g  
t c c c a a g a g a  
t g c t t g t t t g  
g g g g a t g a c a  
g t t c c a c t t t  
g t c a c t c c t c  
c t t a a c c g g g  
a c c a t t c c a c
a a c t t t t g g g
a a g c t c a t c a
c a a a g a a a g g
a c t c c c a a c c
a t t t g a t c t t
t g a a g a t g c c
a t a a a c t g a a
t t a t t c c a c t
a c a a t g a t g t
t c c c a g c c t c
a a g t t g t g a t
a a c c a t c c a a
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A Y 2 6 2 0 6 4  2 6 7 3  b p  D N A  l i n e a r  V R T  2 5 - M A R - 2 0 0 3
X e n o p u s  l a e v i s  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  5 '  f l a n k i n g  
r e g i o n  ( c l o n e  x g H I F l a - 4 )  g e n o m i c  s e q u e n c e .
A Y 2 6 2 0 6 4  
A Y 2  6 2  0  6 4
A f r i c a n  c l a w e d  f r o g .
X e n o p u s  l a e v i s
E u k a r y o t a ;  M e t a z o a ;  C h o r d a t a ;  C r a n i a t a ;  V e r t e b r a t a ;  
E u t e l e o s t o m i ;  A m p h i b i a ;  B a t r a c h i a ;  A n u r a ;  M e s o b a t r a c h i a ;  
P i p o i d e a ;  P i p i d a e ;  X e n o p o d i n a e ;  X e n o p u s .
1  ( b a s e s  1  t o  2 6 7 3 )
S i p e , C . W .  a n d  S a h a , M . S .
C l o n i n g  a n d  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  u p s t r e a m  
r e g u l a t o r y  r e g i o n s  o f  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  i n  
X e n o p u s  l a e v i s  
U n p u b l i s h e d
2  ( b a s e s  1  t o  2 6 7 3 )
S i p e , C . W .  a n d  S a h a , M . S .
D i r e c t  S u b m i s s i o n
S u b m i t t e d  ( 2 5 - M A R - 2 0 0 3 )  B i o l o g y ,  C o l l e g e  o f  W i l l i a m  a n d  
M a r y ,  P . O .  B o x  8 7 9 5 ,  W i l l i a m s b u r g ,  V A  2 3 1 8 5 ,  U S A  
L o c a t i o n / Q u a l i f i e r s  
1 . . 2 6 7 3  
/ o r g a n i s m = " X e n o p u s  l a e v i s "
/ d b  x r e f = " t a x o n : 8 3 5 5 "
/ c l o n e = " x g H I F l a - 4 "
5 ' U T R  2 4 6 0 . . 2 6 7 3
B A S E  C O U N T  8 4 0  a  6 2 3  c  4 7 9  g  7 1 5  t  1 6  o t h e r s
O R I G I N
1  g a a g r g c t a a  a g t t w a a a g g  a a t a c t g k c a  t g g g a a a g a t  g k t a d t t t g a  a a c a t a t c a t
6 1  a a t a g t g c g g  c w c c a g c a g a  a t t c a g c a c t  g a a a t c c a t t  t a c a a a a g a g  c a a a c a g g t t
1 2 1  t t t t a t a t t t  a a t a t a a t t t  a a t a a a t a t g  a c a t g g g g c t  a g a c a t a t t g  t c a g t t t t c c
1 8 1  a g c t g c c c t c  a t g t c a t g t g  a c t t g t g c t c  t g a t a a a t t t  c a g t c a c t c t  t t a c t g c t g t
2 4 1  a c t g c a a g t t  g g a g t g a t a t  c a a c c c c c c c  c c c a a g c a g c  c t a a c a a c a g  a a c a a t g g g a
3 0 1  a g g t a a c c a g  a t a g c a g c t c  c c t a a c a c a a  g a t a a c a g c t  c c c t g g t a g a  t c t a a g a a c a
3 6 1  g c a c t c a a t a  g t a a a a t c c a  g g t c c c a c t g  g g a c a c a t t c  a g t t a t a t t g  a g t a g g a g a a
4 2 1  a c a a c a g c c t  g t c a g a a a g c  a g t t c c a t c c  t a a a g t g c t g  g c t c t a t c t a  a a a g c a c a t g
a a c a g g c a a a  a t g m c t t g a g  a t g t g g c c t a  c m c m c c a a t a  t t a c a a c t a a  a a a a g a a t a c  
a t t t g c t g g t  t c a g g a a t g a  a a t t t t a t a t  g g a a g a g t g a  a t t a t t t g c a  g t g t a a a c t t
LOCUS
DEFINITION
A C C E S S I O N
V E R S I O N
K E Y W O R D S
S O U R C E
O R G A N I S M
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
F E A T U R E S
s o u r c e
4 8 1  
5 4 1  
6 0 1  
6 6 1  
7 2 1  
7 8 1  
8 4 1  
9 0 1  
9 6 1  
1021 
1 0 8 1  
1 1 4 1  
1201 
1 2 6 1
1 3 2 1  t t t g c t t t a g  t a g c c a c a g a  a t g a c a c t g c  c c a g a a t t a g  a c a a c g t g t t  a t c t a c a a a a
a a a c c c t a t a  t c c t t c t c a t  t t a a g g a a a c  t c c c a a c a c a  c t g c c a t t t a
a t a t t a t t t t  t g c c a a a g t g  c a t a a c c t t g  c a t t t a t c a a  c a t t g a a c c t
a g a a a t a a a a  a c t a c a t c a t  a a a a a t c a t g  a c a g a a t c c a  t a g t t a c a t a  g t t a a a t c a g
g t t g a a a a a a  g a c a a a g t c c  a t c a a t t t a a  a c c c t c c a a a  t a a a a a c c c a  g c a t c c a t a c
a c a c a c c c c t  c c a t a c t t t c  a c a t a c a t t a  t a t a t a c c c a  t a g c t a t a c t  a a c t a t a g a g
t w a r g w r t g a  c a a t a g c c t t  t g a t a t g a a t  t c t g t c c a a g  a a a t c a t c c a  a g c c a t t c t t
a a a g g c a t t a  a c t g a a t c a g  c c a t c a c a a c  a t c a c c c g g c  a g t g t a t t c c  a c a a c c t c a c
t g t c c t c a c t  g t g a a g a a c c  c c c t a c g t t g  t t t c a a a t g a  a a g t t c t t t t  c t t c t a g k c t
g a a g g g g t g g  c t c t g g t a c g  c t g a t c c t c t  t t a t g g g t c a  a a a g g t c c c c  t g c t a t t t g t
c t a t a a t g t c  c c c t a a t g t a  c t t g t a a a g t  g t a a t c a t g t  c c c c t c g c a a  g t g c c t t t t t
t c c a g a g a a a  a a a a c c c c a a  c c t t g a c a g t  c t a c c c t c a t  a a t t t a a g t c  t t c c a g c c c t
c t a a c c a g t t  t a g t t g c a c g  t c t c t g c a c t  c t c t c c a g c t  c a t t t a t a t c  c c t c t t a a g g
a c t g g a g t c c  a a a a c t g c a c  t g c a t a c t c c  a g a t g a g g c c  t c a c c a g g g a  c c t a t a a a g a
g g c a t a a t t a  t g t t t t c a a t  c c t t g a g t t a  a t g c c c t t t t  t t a t g c a a g a  c a g a a c t t t a
1 3 8 1
1 4 4 1
1 5 0 1
1 5 6 1
g t g t a t a t t t  
c a t t t t c c a g
t t t g c t g c c c  a g t t t t c c a a  t t t a g a c a a a  t c a c t c t g c a  a a g a g g c a g c  a t c c t g c a t g  
g a a c c t a t a g  a t c t g c a c a a  t t t a g t a t c a  t c t g c a a a a a  t a g a a g c a g t  a c t t t c a a t g
1 6 2 1
1 6 8 1
1 7 4 1
1 8 0 1
1 8 6 1
1 9 2 1
1 9 8 1
2 0 4 1
2101
2 1 6 1
2221
2 2 8 1
2 3 4 1
2 4 0 1
2 4 6 1
2 5 2 1
2 5 8 1
2 6 4 1
//
c c c a c c t c c a  
g a a c w c c a c t  
g t c t a t c t t t  
t t a a t t g a a c  
a a a t c a c a t c  
t t a t t a a a a t  
g g a a a t a a a g  
g a t a t g g a t t  
g g t a a a t t g g  
g g g a g t g a g a  
a c g g a g a g a c  
t a c c g g g c a a  
g a g a c c a g c a  
c t g a t t g g c t  
c a a g c a c t t t  
g c g a a a a a a a  
g t a a a a t a t t  
g c g t g t t c c c
g g a c a t t a a t  
a a c a a c a c t g  
t a g c c a g t t c  
c a g t a a c c t t  
c a c t g c c a t c  
c c c t a a c t t g  
t t g a c a c t t t  
c a g c c a a g t g  
a c a t t t c a g a  
g g c g t g a a t t  
a a t a t t g a a a  
g a g t g g g t t a  
a a a g a g t g g g  
c c c g c g a t c t  
c t c c g a a g c g  
a g a a g a a a c a  
c c c t g c c g g g  
c g t g t g g a t t
a a a c a a g r t g  
g t c c a a t t a g  
t c t a t c c a g g  
t t g t g t g g c a  
c c a g a a t c g a  
t g c a a t g t c a  
t t g t a a t t a a  
a a g t t g c a c g  
g c a g c t c a a g  
a a c t t t t a c a  
t c a a t t t t c a  
a c g c t c t t c c  
c g t g g c g g a g  
a c g t c c g c g g  
t t t t t g t t t g  
c c g c g a t c g t  
g t t g c c g g a g  
a c a a t a g c c c
a a a a g c a a g g  
a a a a t g t t c c  
a a c a a a t a c t  
c t g t a t c a a a  
g g t c c c t g c t  
c t g g a g t t c t  
a g c t g c a a c t  
c t t t t g t a c c  
t t a a a t a a t g  
c a c a t a a a a a  
a a g c c g a c a t  
g c a a a t c g g c  
a c g t c g a g g g  
c a g c t c g a a c  
c g t t g a a t c a  
a c g g t c g g a t  
a g a t c t g a c c  
t t t
g a c c t a g a a c  
a t t t a c c a c c  
a t a t t c c a g g  
t g c t t t a g c a  
c a c c t t c t c a  
a g g a g a a a c t  
t t g t a g t g g c  
a t g t t c c c a a  
a t a a a a t a c a  
t g t a a a t a t c  
a a g a g a c a t t  
t t c c g c c a a c  
c t c g g t c a t g  
t g c a c a c c c a  
g g a g t c a g c g  
t a a a c c g g a g  
t t g c c a a c g a
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A Y 2 6 2 0 6 5  2 7 4 7  b p  D N A  l i n e a r  V R T  2 5 - M A R - 2 0 0 3
X e n o p u s  l a e v i s  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  5 '  f l a n k i n g  
r e g i o n  ( c l o n e  x g H I F l a - 3 )  g e n o m i c  s e q u e n c e .
A Y  2  6 2  0  6 5  
A Y 2 6 2 0 6 5
A f r i c a n  c l a w e d  f r o g .
X e n o p u s  l a e v i s
E u k a r y o t a ;  M e t a z o a ;  C h o r d a t a ;  C r a n i a t a ;  V e r t e b r a t a ;  
E u t e l e o s t o m i ;  A m p h i b i a ;  B a t r a c h i a ;  A n u r a ;  M e s o b a t r a c h i a ;  
P i p o i d e a ;  P i p i d a e ;  e n o p o d i n a e ;  X e n o p u s .
1  ( b a s e s  1  t o  2 7 4 7 )
S i p e , C . W .  a n d  S a h a , M . S .
C l o n i n g  a n d  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  u p s t r e a m  
R e g u l a t o r y  e g i o n s  o f  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  i n  
X e n o p u s  l a e v i s  
U n p u b l i s h e d
2  ( b a s e s  1  t o  2 7 4 7 )
S i p e , C . W .  a n d  S a h a , M . S .
D i r e c t  S u b m i s s i o n
S u b m i t t e d  ( 2 5 - M A R - 2 0 0 3 )  B i o l o g y ,  C o l l e g e  o f  W i l l i a m  a n d  
M a r y ,  P . O .  B o x  8 7 9 5 ,  W i l l i a m s b u r g ,  V A  2 3 1 8 5 ,  U S A  
L o c a t i o n / Q u a l i f i e r s  
1 .  .  2 7 4 7  
/ o r g a n i s m = " X e n o p u s  l a e v i s "
/ d b _ x r e f = " t a x o n : 8 3 5 5 "
/ c l o n e = " x g H I F l a - 3 "
5  T U T R  2 5 0 4 .  . > 2 7 4 7
B A S E  C O U N T  8 5 3  a  6 5 1  c  4 9 5  g  7 3 7  t  1 1  o t h e r s
O R I G I N
1  c a t t g g g c t c  a a c c a t t t t g  c c t g c c a g a a  a a t a c c g g c c  a g g k g g c a a c  c c t a g c c c a g
a a t g c t a a a g  t a a a g a a t a c  g g c a g g g a a a  a a a g k t t t t t  g a a a c a c a t c  a t a a t a g g c c
g c c c c a g c a g  a a t t c a g c a c  t g a a a t c c a t  t t a c a a a a g a  g c a a a c a g g t  t t t t t a c a t t
LOCUS
DEFINITION
A C C E S S I O N
V E R S I O N
K E Y W O R D S
S O U R C E
O R G A N I S M
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
F E A T U R E S
s o u r c e
6 1
121
1 8 1
2 4 1
3 0 1
3 6 1
4 2 1
4 8 1
5 4 1
6 0 1
6 6 1
t a a c a t a a t a  t a a t a a a t a g  g a c a t t g g g c  t a g a c a t a t t  g t c a g t t t t t  c a g c t g c c c y
c a t g c a t g t g  a c t t g t g c t c  t g a t a a a t t t  c a g t c a c t c t  t t a c t g c t g t  a c y g c a a g t t
g g a g t g a t a t  c a c c c c c c c c  c c a a g c a g c c  t a a c a a c a g a  a c a a t g g g a a  g g t a a c c a g a
t a g c a g c t c c  c t a a c a c a a g  a t w a c a g c t k  c c t g g t a g a t  c t a a g a a c a g  c t c t c a a t a g
t a a a a t c c a g  g t c c c a c t g g  g a c a c a t t c a  g t t a c a t t g a  g t a g g a g a a a  c a a c a g c c t g
t c a g a a a g c a  g t t c c a t c c t  a a a g t g c t g g  c t c t t t c t g a  a a g c a c a t a a  a c a g g c a a a a
t t a c c t g a g a  t g g c t g c t t a  c a c a c c a a t a  t t a c a a c t a a  a a a a g a a t a c  a t t t g c t g g t
t c a g g a a t g a  a a t t t t a t a t  g g t a g a g t g a  a t t a t t t g c a  g t g t a a a c k t  a g a a a t a a a a
a c t a c a t c a t  a a a a a t c a t g  a c a g a a t c c a  t a g t t a c a t a  a t t a a a t c a g  g t t g g a a a a a
7 2 1  g a c a a a g t c c  a t c a a g t t c a  a c c c c t c c a a  a t g a a a a c c c  a g c a t c c a t a  c a c a c a c c c c
7 8 1  t c c a t m c t t t  c a c a t a c a t t  a t a t a t a c c c  a t a t c t a t a c  t a a a g c g t t t  a g t a t c a a a a
c c a a g a a a t c  a t c c a a g c c a  c t c t t a a a g g  c a t t a a c t g a8 4 1  g c c t t t g a t a  t g a a t t c t g t  
9 0 1  
9 6 1
1 0 2 1  g g t a c g g t g a  t c c a c t t t a t  g g g t a a a a a g  g t c c c c t g c t
a t c a g c c a t c  a c a a c a t c a c  c c g g c a g t g c  a t t c c a c a a c  c t c a c t g t c c  t c a c t g t g a a  
g a a c c a c c t a  c g t t g c t t c a  a a t g a a a g t t  c t t t t c t t c t  a g t c t a a a g g  g g t g g c c t c t
a t t t g t c t a t  a a t g t c c t c t  
1 0 8 1  a a t g t a c t t g  t a a a g t g t a a  t c a t g t c c c c  t t g c a a g t g c  t t t t t t t c c a  g a g a a a a c a a
1 1 4 1  t c c c a a c c t t  g a c a a t c c c t  c a t a a t t t a a  g t c t t c c a t c  c c t c t a a c c a  a t t t a g t t g c
1 2 0 1  a c a t c t c t g a  a c t c t c t c t c  c a g c t c a t t t  a t a t c c c t c t  t a a g g a c t g g  a g t c c a a a a c
1 2 6 1  
1 3 2 1  
1 3 8 1  
1 4 4 1
1 5 0 1  t t g c c a a a g t  g c a t a a c c t t  g c a t t t a t c a  a c a t t g a a c c  t c a t t t t c c a  g t t t g c t g a g
1 5 6 1  c a g t t t t c c a  g c t t a g a c a a  a t c a c t c t g c  a a a g a g g c a g  c a t c c t g c a t  g g a a c c t a t a
t g c a c t g c a t  a c t c c a g a t g  a g g c c t t a c c  a g g g a c c t a t  a a a g a g g c a t  a a t t a t g t t t
t c a t c c c t t g  a g t t a a t g c c  c t t t t t t a t g  c a a g a c a g a a  c t t t a t t t g c  t t t a g t a t t c
a c a g a a t g a c  a c t g c c c a g a  a t t a g a c a a c  t t g t t a t c t a  c a a a a a c c c c  a a g a t c c t t c
t c a t t g a a g g  a a a c t c c c a a  c a c a c t g c c a  t t t a g t g t a t  a a c t t g c a t t  t a t a t t a t t t
1 6 2 1
1 6 8 1
1 7 4 1
1 8 0 1
1 8 6 1
1 9 2 1
1 9 8 1
2 0 4 1
2101
2 1 6 1
2221
2 2 8 1
2 3 4 1
2 4 0 1
2 4 6 1
2 5 2 1
2 5 8 1
2 6 4 1
2 7 0 1
//
g t t c t g c a c a  
a g t t c a t t a a  
t a a c a a c a c t  
t t a g c c a g t t  
c c a g t a a c c t  
c c a c t g c c a t  
t c c c t g t g c a  
c a c t t t t c g t  
c a a g t g a a g t  
t c a g a g c a g t  
g a a t t a a c t t  
g a a a t c a a t t  
g t t a a c g c t c  
t g g g c g t g g c  
a t c t a c g t c c  
a g c g t t t t t g  
a a c a c c g c g a  
g g g g t t g c c g  
g t g t a t t a c a
a t t t a g t a t c  
t a a a c a a g t t  
g g t c c a a t t a  
c t c t a t c c a g  
t t t g t g t g g c  
c c c a g a a t t g  
a t a t c a c t g g  
a a t t a a a g c t  
t g c a c g c t t t  
t c a a g t t a a a  
t t a c a c a t a a  
t t g a a a g c c g  
t t c c g c a a a t  
g g a g a c g t c g  
g c g g c a g c t c  
t t t g c g t t g a  
t c g t a c g g t c  
g a g a g a t c t g  
a t a g c c t t t c
a t c t g c a a a a  
g a a a a g c a a g  
g a a a a t g t t c  
g t a c a a a t a c  
a c t g t a t c a a  
a g g t c c c t g c  
a g t t c t a g g a  
g c a a c t t t g t  
g c a c c a t g t t  
t a a t g a t a a a  
a a a a t g t a a a  
a c a t a a g a g a  
y s g c t t c c g c  
a g g g c t c g g t  
g a a c t g c a c a  
a t c a g g a g t c  
g g a t t a a a c c  
a c c t t g c c a a  
a g c t a g g c c c
a t a g a a a c a g
g g a c c t a g t a
c a t t t a c c a c
t a t g t t t c a g
a t g c t t t a g c
t c a c g t t c t c
g a a g c t t t g c
a g t g g c c a a a
c c c a a t a a t a
a t a c a t t t c c
t a t c t c a a c g
c a t t c c c t a c
c a a c c c c t c c
c a t g t g c g a c
c c c a c t c g g t
a g c g a g t g a a
g g a g g g a t t g
c g c a a t c g t c
t c g g t t t c t g
t a c t t t c a a t  
c a g a g c c t g c  
c a c t c t t t g t  
g c c a a c a t t c  
a a a g t c t a a g  
a t a a a a a g a a  
a t t g t g g g a a  
a t g t c t g a t a  
c a t a a g g t a a  
c t g c t g g g a g  
t c a g a c g g a g  
t a c g t a c c g g  
c a c c g a g a c c  
t t t c c t g a t t  
g a c g c a a g c a  
c c g g g c g a a a  
c g t c g t a a a a  
t t t c g c g t g t  
c g c t g c a
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LOCUS
DEFINITION
A C C E S S I O N
V E R S I O N
K E Y W O R D S
S O U R C E
O R G A N I S M
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
F E A T U R E S
s o u r c e
V R T  2 5 - M A R - 2 0 0 3  
a l p h a  5 '  f l a n k i n g
A Y 2 6 2 0 6 6  3 1 0 0  b p  D N A  l i n e a r
X e n o p u s  l a e v i s  h y p o x i a - i n d u c i b l e  f a c t o r  1  
r e g i o n  ( c l o n e  x g H I F l a - 2 )  g e n o m i c  s e q u e n c e  
A Y  2  6 2  0  6 6  
A Y 2  6 2 0 6 6
A f r i c a n  c l a w e d  f r o g .
X e n o p u s  l a e v i s
E u k a r y o t a ;  M e t a z o a ;  C h o r d a t a ;  C r a n i a t a ;  V e r t e b r a t a ;  
E u t e l e o s t o m i ;  A m p h i b i a ;  B a t r a c h i a ;  A n u r a ;  M e s o b a t r a c h i a ;  
P i p o i d e a ;  P i p i d a e ;  X e n o p o d i n a e ;  X e n o p u s .
1  ( b a s e s  1  t o  3 1 0 0 )
S i p e , C . W .  a n d  S a h a , M . S .
C l o n i n g  a n d  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  u p s t r e a m  
R e g u l a t o r y  r e g i o n s  o f  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  i n  
X e n o p u s  l a e v i s  
U n p u b l i s h e d
2  ( b a s e s  1  t o  3 1 0 0 )
S i p e , C . W .  a n d  S a h a , M . S .
D i r e c t  S u b m i s s i o n
S u b m i t t e d  ( 2 5 - M A R - 2 0 0 3 )  B i o l o g y ,  C o l l e g e  o f  W i l l i a m  a n d  
M a r y ,  P . O .  B o x  8 7 9 5 ,  W i l l i a m s b u r g ,  V A  2 3 1 8 5 ,  U S A  
L o c a t i o n / Q u a l i f i e r s
1 . . 3 1 0 0
/ o r g a n i s m = " X e n o p u s  l a e v i s "
/ d b _ x r e f = " t a x o n : 8  3 5 5 "
/ c l o n e = " x g H I F l a - 2 "
2 6 1 4 . . 2 9 1 5
g9 2 5  a 7 2 6  c 5 6 0 8 2  o t h e r s
5  '  U T R  
B A S E  C O U N T  
O R I G I N
1  c c c c t g c t c a  t g t g a t g a t k  c c c a r a t a g g  g t t g c c a c c t  t t t c t g g a a a  a a a a a a a t a a
6 1  a g g c c t t c c t  a t a t a t t t a w  c t t t t t c c c t  a t t a a t a a c a  t t k g g c t c a a  c c a t c a t t t t
1 2 1  k c c t k c c a g t  a a a a t a c c g g  c c a g g t g g c a  a c c c t a t g c c  c c a g a a t t g c  t a a a g t t a a a
1 8 1  g g a a t a c t g t  c a t g g g a a a a  a a t g t t t t t t  g a a a c a c a t c  a t a a t a g t g c  k c t c a c a g c a
2 4 1  g a a t t c a g c a  c t g a a a t c c a  t t t a c a a a a g  a g c a a a c a g g  t t t t t t a c a t  t t a a c a t a a t
3 0 1  t t a a t a a a t a  t g a c a t t g g g  c t a g a c a t a t  t g t c a g t t t t  t t c a g c t g c c  c t c a t g t c a t
3 6 1  g t g a c t t g t g  c t c t g a t a a a  t t t c a g t c a c  t c t t t a c t g c  t g t a c t g c a a  g t t g g a g t g a
4 2 1  t a t c a c c c c c  c c c c c a a g c a  g c c t a a c a a c  a g a a c a a t g g  g a a g g t a a c c  a g a t a g c a g c
4 8 1  t c c c t a a c a c  a a g a t a a c a g  c t g c c t g g t a  g a t c t a a g a a  c a g c w c t c a a  t a g t a a a a t c
5 4 1  c a g g t c c c a c  t g g g a c a c a t  t c a g t t a c a t  t g a g t a g g a g  a a a c a a c a k c  c t g t c a g a a a
6 0 1  g c a g t t c c a t  c c t a a a g t g c  t g g c t c t t t c  t g a a a g c a c a  t a a a c a g g c a  a a a t t w c c t g
6 6 1  a g a t g g c t g c  t t a c a c w c c a  a t a t t a c a a c  t a a a a a a g a a  t a c a t t t g c t
7 2 1  t g a a a t t t t a  t a t g g t a g a g  t g a a t t a t t t  g c a g t g t a a m  c t t a g a a a t a
7 8 1  y a t a a a a a t c  a t g a c a g a a t  c c a t a r w t a c  a t a a t t a a a t
8 4 1  t c c a t c a a g t  t c a a c c c c t c  c a a a t g a a a c  c c c m s c m t c c  a t a c a c a c a c  c c c t c c a t m c
9 0 1  t t t c a c a t a c  a t t a t a t a t a  c c c a t a t c t a  t a c t a a a g c g  t t t a g t a t c a  a a a g c c t t t g
9 6 1  a t a t g a a t t c  t g t c c a a g a a  a t c a t c c a a g  c c a c t c t t a a  a g g c a t t a a c  t g a a t c a g c c
1 0 2 1  a t c a c a a c a t  c a c c c g g c a g  t g c a t t c c a c  a a c c t c a c t g  t c c t c a c t g t  g a a g a a c c a c
1 0 8 1  c t a c g t t g c t  t c a a a t g a a a  g t t c t t t t c t  t c t a g t c t a a  a g g g g t g g c c  t c t g g t a c g g
1 1 4 1  t g a t c c a c t t  t a t g g g t a a a  a a g g t c c c c t  g c t a t t t g t c  t a t a a t g t c c  t c t a a t g t a c
1 2 0 1  t t g t a a a g t g  t a a t c a t g c c  c c t t g c a a g t  c t t t t t t t c c  a g a g a a a a c a  a t c c c a a c c t
1 2 6 1  t g a c a t t c c c  t c a t a a t t t a  a g t c t t c c m t  c c c t c t a a c c  a a t t t a g t t g  c a c a t c t c t g
1 3 2 1  a a c t c t c t c t  c c a g c t c a t t  t a t a t c c c t c  t t a a g g a c t g  g a g c c a a a a c  t g c a c t g c a t
1 3 8 1  a c t c c a g a t g  a g g c t t a c c a  g g g a c c t a t a  a a g a g g c a t a  a t t a t g t t t t  c a t c c c t t g a
1 4 4 1  g t t a a t g c c y  t t t t t t a t g c  a a g a c a g a a c  t t t a t t t g c t  t t a g t a t t c a  c a g a a t g a c a
1 5 0 1  g t g c c c a g a a  t t a g a c a a c t  t g t t a t g t a g  a a a a a c c c c a  a g a t c c t t c t  c a t t g a a g g a
1 5 6 1  a a c t c c c a a c  a c a c t g c c a t  t t a g t g t a t a  a c t t g c a t t t  a t a t t a t t t t  t g c c a a a g t g
g g t t c a g g a a  
a a a m m t a c a t  
c a g g t t g g a a  a a a g a c a a a g
46
1 6 2 1  c a t a a c c t t g  c a t t t a t c a a  c a t t g a a c c t  c a t t t t c c a g  t t t g c t g a g c  a g t t t t c c a g
1 6 8 1  c t t a g m c a a a  t c y c t c t g c a  a a g a g g c m g c  w t c c t g c a t g  g a a c c t a t a g  t t c t g c m c a a
1 7 4 1  t t t a g t w t c w  t c t g c a a a a a  t a g a a a c a g t  w c t t t c a m t g  c c c m c c t c c a  g t t c a t t a a t
1 8 0 1  a a a c a a g t t g  a a a a g c a a g g  g a c c t a g t a c  a g a g c c t g c g  k t a c t c c a c t  a a c a a c a c t g
1 8 6 1  g k c c a a t t a g  a a a a t g t t c c  a t t t a c c a c c  a c t c t t t g t a  g t c t a t c t t t  t a g c c a g t t c
1 9 2 1  t c t a t c c a g g  w a c a a a t a c t  a t g t t t c a g g  c c a c c a t t c c  t t a a t t t a a c  c a g a t a m c c t
1 9 8 1  t t t g t g t g g c  a c t g t a t c a a  a t g c t t t a g c  a a a g t c t a a g  t a a a t c a c a t  c c a c t g c c a t
2 0 4 1  c c c a g a a t t g  a g g t c c c t g c  t c a c g t t c t c  a t a a a a a g a a  a t t a t t a a a a  t c c c t g t g c a
2 1 0 1  a t a t c a c t g g  a g t t c t a g g a  g a a g c t t t g c  a t t g t g g g a a  a t a a a g t t g a  c a c t t t t c g t
2 1 6 1  a a t t a a a g c t  g c a a c t t t g t  a g t g g c c a a a  a t g t c t g a t a  t g g a t t c a g c  c a a g t g a a g t
2 2 2 1  t g c a c g c t t t  g c a c c a t g t t  c c c a a t a a t a  c a t a a g g t a a  a t t g g a c a t t  t c a g a g c a g t
2 2 8 1  t c a a g t t a a a  t a a t g a t a a a  a t a c a t t t c c  c t g c t g g g a g  t g a g a g g c g t  g a a t t a a c t t
2 3 4 1  t t a c a c a t a a  a a a a t g t a a a  t a t c t c a a c g  t c a g a c g g a g  a g a c a a t a t t  g a a a t c a a t t
2 4 0 1  t t g a a a g c c g  a c a t a a g a g a  c a t t c c c t a c  t a c g t a c c g g  g c a a g a g t g g  g t t a a c g c t c
2 4  6 1  t t c c g c a a a t  c g g c t t c c g c  c a a c c c c t c c  c a c c g a g a c c  a g c a a a a g a g  t g g g c g t g g c
2 5 2 1  g g a g a c g t c g  a g g g c t c g g t  c a t g t g c g a c  t t t c c t g a t t  g g c t c c c g c g  a t c t a c g t c c
2 5 8 1  g c g g c a g c t c  g a a c t g c a c m  c c c m c t c g g t  g a c g c a a g c m  c t t t c t c c g a  a g c g t t t t t g
2 6 4 1  t t t g c g t t g a  a t c a g g a g t c  a g c g a g t g a a  c c g g g c g a a a  a a a a a g a a g a  a a c a c c g c g a
2 7 0 1  t c g t a c g g t c  g g a t t a a a c c  g g a g g g a t t g  c g t c g t a a a a  t a t t c c c t g c  c g g g g t t g c c
2 7  6 1  g g a g a g a t c t  g a c c t t g c c a  a c g a a t c g t c  t t t c g c g t g t  t c c c t g t g t g  g a t w a c a a t a
2 8 2 1  g c c c t t t t c a  g t a g g g c c c t  c g g t t t c t g c  g t b y m y a g g a  c a a w w y c c t c  g s c k c t t b m c
2 8 8 1  a y m k t t m c g g  a g c g c c c c t c  c c c c a c w c g t  t w g g c a t g g a  g g k a t c a g g a  g t a g t g a a c g
2 9 4 1  a g a a g g a a a d  g t g a k g g t a c  g c c w c c w t g c  a c g t a g s c c a  c w g a c c a g c a  a a c w c c c a a g
3 0 0 1  g c c t w g c t w g  a c a c c g a a a c  c t r t w a g k g a  g t b c t g s c m a  a g a c t t t g a a  w g a g c k g c a g
3 0 6 1  a c a a a a g a r a  g c g y a c m a a a  g g a c a c a g r g  g c a a a v c g g r
/ /
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L O C U S  Y 2 6 2 0 6 7  2 8 2 5  b p  D N A  l i n e a r  V R T  2 5 - M A R - 2 0 0 3
D E F I N I T I O N  X e n o p u s  l a e v i s  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  5 '  f l a n k i n g  
r e g i o n  ( c l o n e  x g H I F l a - 5 )  g e n o m i c  s e q u e n c e .
A C C E S S I O N  A Y 2  6 2 0  6 7
V E R S I O N  A Y 2  6 2  0  6 7
K E Y W O R D S
S O U R C E  A f r i c a n  c l a w e d  f r o g .
O R G A N I S M  X e n o p u s  l a e v i s
E u k a r y o t a ;  M e t a z o a ;  C h o r d a t a ;  C r a n i a t a ;  V e r t e b r a t a ;  
E u t e l e o s t o m i ;  A m p h i b i a ;  B a t r a c h i a ;  A n u r a ;  M e s o b a t r a c h i a ;  
P i p o i d e a ;  P i p i d a e ;  X e n o p o d i n a e ;  X e n o p u s .
R E F E R E N C E  1  ( b a s e s  1  t o  2 8 2 5 )
A U T H O R S  S i p e ,  C  .  W .  a n d  S a h a , M . S .
T I T L E  C l o n i n g  a n d  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  u p s t r e a m
R e g u l a t o r y  r e g i o n s  o f  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  i n  
X e n o p u s  l a e v i s  
J O U R N A L  U n p u b l i s h e d
R E F E R E N C E  2  ( b a s e s  1  t o  2 8 2 5 )
A U T H O R S  S i p e ,  C  .  W .  a n d  S a h a , M . S .
T I T L E  D i r e c t  S u b m i s s i o n
J O U R N A L  S u b m i t t e d  ( 2 5 - M A R - 2 0 0 3 ) B i o l o g y ,  C o l l e g e  o f  W i l l i a m  a n d
M a r y ,  P . O .  B o x  8 7 9 5 ,  W i l l i a m s b u r g ,  V A  2 3 1 8 5 ,  U S A  
F E A T U R E S  L o c a t i o n / Q u a l i f i e r s
s o u r c e  1 . . 2  8 2 5
/ o r g a n i s m ^ " X e n o p u s  l a e v i s "
/ d b _ x r e f = " t a x o n : 8  3 5 5 "
/ c l o n e = " x g H I F l a - 5 "
5 ' U T R  2 4 4 7 . . 2 7 4 6
g e n e  2 7 4 7 . . > 2 8 2 5
/ g e n e = " H I F - l a "
C D S  2 7 4 7 . . > 2 8 2 5
/ g e n e = " H I F - l a "
/ n o t e = " t r a n s c r i p t i o n  f a c t o r "
/ c o d o n _ s t a r t = l
/ p r o d u c t = " h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a "
/ t r a n s l a t i o n = " M E G S X X X N E X K R G E X T C X E R X T L X X I "
B A S E  C O U N T  8 7 5  a  6 4 3  c  5 2 8  g  7 5 3  t  2 6  o t h e r s
O R I G I N
1  g t g a a a a g t t  a a a g g a a t g k  t k t c a t g g r a  a a a a a t g t t t  t t t g a a a a a w  a t d a k a a t a g
6 1  t g c t g c g a c a  g g a g a a t t c a  g c g c k g a a a t  g t a t t t g t a a  a a g a g g a a a c  a g g t t t t t t a
1 2 1  c a t t t a a c a t  a a t t t a a t a a  a t a t g a c a t t  g g g c t a g a c a  t a t t g t c a g t  t t t t c a g c t g
1 8 1  c c c t c a t g t c  a t g t g a c t t g  t g c t c t g a t a  a a t t t c a g t c  a c t c t t t a c t  g c t g t a c t g c
2 4 1  a a g t t g g a g t  g a t a t c a c c c  c c c c c c c a a g  c a g c c t a a c a  a c a g a a c a a t  g g g a a g g t a a
3 0 1  c c a g a t a g c a  g c t c c c t a a c  a c a a g a t a a c  a g c t g c c t g g  t a g a t c t a a g  a a c a g c a c t c
3 6 1  a a t a g t a a a a  t c c a g g t c c c  a c t g g g a c a c  a t t c a g t t a c  a t t g a g t a g g  a g a a a c a a c a
4 2 1  g c c t g t c a g a  a a g c a g t t c c  a t c c t a a a g t  g c t g g c t c t t  t c t g a a a g c a  c a t a a a c a g g
4 8 1  c a a a a t t a c c  t g a g a t g g c t  g c t t a c a c a c  c a a t a t t a c a  a c t a a a a a a g  a a t a c a t t t g
5 4 1  c t g g t t c a g g  a a t g a a a t t t  t a t a t g g t a g  a g t g a a t t a t  t t g c a g t g t a  a d c t t a g a a a
6 0 1  t a a a a a c t a c  a t c a t a a a a a  t c a t g a c a g a  a t c c a t a g t t  a c a t a a t t a a  a t c a g g t t g g
6 6 1  a a a a a a a c a a  a g t c c a t c a a  g t t c a a c c c c  t c c a a a t g a a  a a c c c a g c a t  c c a t a c a c a c
7 2 1  a c c c c t c c a t  a c t t t c a c a t  a c a t t a t a t a  t a c c c a t a t c  t a t a c t a a a g  c g t t t a g t a t
7 8 1  c a a a a g c c t t  t g a t a t g a a t  t c t g t c c a a g  a a a t c a t c c a  a g c c a c t c t t  a a a g g c a t t a
8 4 1  a c t g a a t c a g  c c a t c a c a a c  a t c a c c c g g c  a g t g c a t t c c  a c a a c c t c a c  t g t c c t c a c t
9 0 1  g t g a a g a a c c  a c c t a c g t t g  c t t c a a a t g a  a a g t t c t t t t  c t t c t a g t c t  a a a g g g g t g g
9 6 1  c c t c t g g t a c  g g t g a t c c a c  t t t a t g g g t a  a a a a g g t c c c  c t g c t a t t t g  t c t a t a a t g t
1 0 2 1  c c t c t a a t g t  a c t t g t a a a g  t g t a a t c a t g  t c c c c t t g c a  a g t g c t t t t t  t t c c a g a g a a
1 0 8 1  a a c a a t c c c a  a c c t t g a c a a  t c c c t c a t a a  t t t a a g g c t t  c c t c c c t c t a  a c c a a t t t a g
1 1 4 1
1201
1 2 6 1
1 3 2 1
1 3 8 1
1 4 4 1
1 5 0 1
1 5 6 1
1 6 2 1
1 6 8 1
1 7 4 1
1 8 0 1
1 8 6 1
1 9 2 1
1 9 8 1
2 0 4 1
2101
2 1 6 1
2221
2 2 8 1
2 3 4 1
2 4 0 1
2 4 6 1
2 5 2 1
2 5 8 1
2 6 4 1
2 7 0 1
2 7 6 1
2 8 2 1
//
t g c a c a t e t c  
a c t g c a c t g c  
t t t c a t c c c t  
t c a c a g a a t g  
t c t c a t t g a a  
t t t t g c c a a a  
a g c a g t t t t c  
t a g t t c t g c a  
c c a g t t c a t t  
c a c t a a c a a c  
c t t t t a g c c a  
t a a c c a g t a a  
c a t c c a c t g c  
a a a t c c c t g t  
t g a c a c t t t t  
a g c c a a g t g a  
a t t t c a g a g c  
c g t g a a t t a a  
a t t g a a a t c a  
t g g g t t a a c g  
g a g t g g g c g t  
g c g a t c t a c g  
e g a a g e g t t t  
a g a a a c a c c g  
g e e g g g g t t g  
t r g a t t a c a a  
c g g c g c t t g a  
a g k a g w g a a c  
s a t t a
t g a a c t c t c t  
a t a c t c c a g a  
t g a g t t a a t g  
a c a g t g c c c a  
g g a a a c t c c c  
g t g c a t a a c c  
c a g c t t a g a c  
c a a t t t a g t a  
a a t a a a c a a g  
a c t g g t c c a a  
g t t c t c t a t c  
c c t t t t g t g t  
c a t c c c a g a a  
g c a a t a t c a c  
c g t a a t t a a a  
a g t t g e a e g e  
a g t t c a a g t t  
c t t t t a c a c a  
a t t t t g a a a g  
c t c t t c c g c a  
g g c g g a g a c g  
t c c g c g g c a g  
t t g t t t g c g t  
c g a t c g a a c g  
c c g g a g a g a t  
t a g c c c t t t m  
m a c a g c t t c g  
g a g n a g a a g a
c t c c a g c t c a  
t g a g g c c t t a  
c c c t t t t t t a  
g a a t t a g a c a  
a a c a c a c t g c  
t t g e a t t t a t  
a a a t c a c t c t  
t c a t c t g c a a  
t t g a a a a g c a  
t t a g a a a a t g  
c a g g t a c a a a  
g g c a c t g t a t  
t t g a g g t c c c  
t g g a g t t c t a  
g c t g c a a c t t  
t t t g c a c c a t  
a a a t a a t g a t  
t a a a a a a t g t  
c c g a c a t a a g  
a a t c g g c t t c  
t c g a g g g c t c  
c t c g a a c t g c  
t g a a t c a g g a  
g t c g g a t t a a  
c t g a c c t t g c  
a g w a g g g c c c  
g a g c g t c c c t  
g g g g a g a g t s
t t t a t a t c c c  
c c a g g g a c c t  
t g c a a g a c a g  
a c t t g t t a t g  
c a t t t a g t g t  
c a a c a t t g a a  
g c a a a g a g g c  
a a a t a g a a a c  
a g g g a c c t a g  
t t c c a t t t a c  
t a c t a t g t t t  
c a a a t g c t t t  
t g e t c a c g t t  
g g a g a a g c t t  
t g t a g t g g c c  
g t t c c c a a t a  
a a a a t a c a t t  
a a a t a t c t c a  
a g a c a t t c c c  
c g c c a a c c c c  
g g t c a t g t g c  
a c a c c c a c t c  
g t c a g c g a g t  
a c c g g g g g a t  
c a a c g a a t c g  
t e g g t t t c t g  
c c c c c c c t c g  
c a c s t g c a w t
t c t t a a g g a c  
a t a a a g a g g c  
a a c t t t a t t t  
t a g a a a a a c c  
a t a a c t t g c a  
c c t c a t t t t c  
a g c a t c c t g c  
a g t a c t t t c a  
t a c a g a g c c c  
c a c c a c t c t t  
c a g g c c a a c a  
a g c a a a g t c t  
c t c a t a a a a a  
t g c a t t g t g g  
a a a a t g t c t g  
a t a c a t a a g g  
t c c c t g c t g g  
a c g t c a g a c g  
t a c t a c g t a c  
t c c c a c c g a g  
g a c t t t c c t g  
g g t g a c g c a a  
g a a c c g g g c g  
t g c g t c g t a a  
w c t t t c a a g t  
c r t g c a t a g a  
a t t g g a a t g g  
g a a c g g t g s a
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LOCUS
DEFINITION
A C C E S S I O N
V E R S I O N
K E Y W O R D S
S O U R C E
O R G A N I S M
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
R E F E R E N C E
A U T H O R S
T I T L E
J O U R N A L
F E A T U R E S
s o u r c e
A Y 2 6 2 0 6 8  2 4 9 8  b p  D N A  l i n e a r  V R T  2 5 - M A R - 2 0 0 3
X e n o p u s  l a e v i s  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  5 1 f l a n k i n g  
r e g i o n  ( c l o n e  x g H I F l a - 1 )  g e n o m i c  s e q u e n c e .
A Y  2  6 2  0  6 8  
A Y 2  6 2  0  6 8
A f r i c a n  c l a w e d  f r o g .
X e n o p u s  l a e v i s
E u k a r y o t a ;  M e t a z o a ;  C h o r d a t a ;  C r a n i a t a ;  V e r t e b r a t a ;  
E u t e l e o s t o m i ;  A m p h i b i a ;  B a t r a c h i a ;  A n u r a ;  M e s o b a t r a c h i a ;  
P i p o i d e a ;  P i p i d a e ;  X e n o p o d i n a e ;  X e n o p u s .
1  ( b a s e s  1  t o  2 4 9 8 )
S i p e , C . W . ,  G r u b e r , E . J .  a n d  S a h a , M . S .
C l o n i n g  a n d  f u n c t i o n a l  c h a r a c t e r i z a t i o n  o f  u p s t r e a m  
R e g u l a t o r y  r e g i o n s  o f  h y p o x i a - i n d u c i b l e  f a c t o r  1  a l p h a  i n  
X e n o p u s  l a e v i s  
U n p u b l i s h e d
2  ( b a s e s  1  t o  2 4 9 8 )
S i p e , C . W .  a n d  S a h a , M . S .
D i r e c t  S u b m i s s i o n
S u b m i t t e d  ( 2 5 - M A R - 2 0 0 3 )  B i o l o g y ,  C o l l e g e  o f  W i l l i a m  a n d  
M a r y ,  P . O .  B o x  8 7 9 5 ,  W i l l i a m s b u r g ,  V A  2 3 1 8 5 ,  U S A  
L o c a t i o n / Q u a l i f i e r s
1 . . 2 4 9 8
/ o r g a n i s m = " X e n o p u s  l a e v i s "
/ d b  x r e f = " t a x o n : 8 3 5 5 "
/ c l o n e = " x g H I F l a - l "
2 1 9 8 . . 2 4 9 8
a  6 0 8  c  4 5 1  g  6 6 5  t  3  o t h e r s7 7 1
5  '  U T R  
B A S E  C O U N T  
O R I G I N
1  a c c c c c c c c c  c a a g c a g c c t
6 1
121
1 8 1
2 4 1
3 0 1
3 6 1
4 2 1
4 8 1
5 4 1
6 0 1
6 6 1
7 2 1
7 8 1
8 4 1
9 0 1
9 6 1
1021
1 0 8 1
1 1 4 1
1201
1 2 6 1
1 3 2 1
1 3 8 1
1 4 4 1
1 5 0 1
1 5 6 1
c a a t g g g a a g  g t a a c c a g a t  a g c a g c t c c c
a a a a t c c a g g
a a c a a c a g a a
t a a c a c a a g a  t a a c a g c t g c  c t g g t a g a t c  t a a g a a c a g c  a c t c a a t a g t  
t c c c a c t g g g  a c a c a t t c a g  t t a c a t t g a g  t a g g a g a a a c  a a c a g c c t g t  
t t c c a t c c t a  a a g t g c t g g c  t c t t t c t g a a  a g c a c a t a a a  
g g c t g c t t a c  a c a c c a a t a t  t a c a a c t a a a  a a a g a a t a c a  t t t g c t g g t t  
a t t t t a t a t g  g t a g a g t g a a  t t a t t t g c a g  t g t a a a c t t a  g a a a t a a a a a
c a g a a a g c a g  
c a g g c a a a a t  t a c c t g a g a t  
c a g g a a t g a a  
c t a c a t c a t a
a a a a t c a t g a  c a g a a t c c a t  a g t t a c a t a a  t t a a a t c a g g  t t g g a a a a a g  a c a a a g t c c a
t c a a g t t c a a  c c c c t c c a a a  t g a a a a c c c a  g c a t c c a t a c  a c a c a c c c c t  c c a t a c t t t c
a c a t a c a t t a  t a t a t a c c c a  t a t c t a t a c t  a a a g c g t t t a  g t a t c a a a a g  c c t t t g a t a t
g a a t t c t g t c  c a a g a a a t c a  t c c a a g c c a c  t c t t a a a g g c  a t t a a c t g a a  t c a g c c a t c a
c a a c a t c a c c  c g g c a g t g c a  t t c c a c a a c c  t c a c t g t c c t  c a c t g t g a a g  a a c c a c c t a c
g t t g c t t c a a  a t g a a a g t t c  t t t t c t t c t a  g t c t a a a g g g  g t g g c c t c t g  g t a c g g t g a t
c c a c t t t a t g  g g t a a a a a g g  t c c c c t g c t a  t t t g t c t a t a  a t g t c c t c t a  a t g t a c t t g t
a a a g t g t a a t  c a t g t c c c c t  t g c a a g t g c t  t t w t t t c c a g  a g a a a a c a a t  c c c a a c c t t g
a c a a t c c c t c  a t a a t t t a a g  t c t t c c a t c c  c t c t a a c c a a  t t t a g t t g c a  c a t c t c t g a a
c t c t c t c t c c  a g c t a c a t t t  a t a t c c c t c t  t a a g g a c t g g  a g t c c a a a a c  t g c a c t g c a t
a c t c c a g a t g  a g g c c t t a c c  a g g g a c c t a t  a a a g a g g c a t  a a t t a t g t t t  t c a t c c c t t g
a g t t a a t g c c  c t t t t t t a t g  c a a g a c a g a a  c t t t a t t t g c  t t t a g t a t t c  a c a g a a t g a c
a c t g c c c a g a  a t t a g a c a a c  t t g t t a t c t a  c a a a a a c c c c  a a g a t c c t t c  t c a t t g a a g g
a a a c t c c c a a  c a c a c t g c c a  t t t a g t g t a t  a a c t t g c a t t  t a t a t t a t t t  t t g c c a a a g t
g c a t a a c c t t  g c a t t t a t c a  a c a t t g a a c c  t c a t t t t c c a  g t t t g c t g a g  c a g t t t t c c a
g c t t a g a c a a  a t c a c t c t g c  a a a g a g g c a g  c a t c c t g c a t  g g a a c c t a t a  g t t c t g c a c a
a t t t a g t a t c  a t c t g c a a a a  a t a g a a a c a g  t a c t t t c a a t  g c c c m c c t c c  a g t t c a t t a a
c t a a c a a c a c  
t t t a g c c a g t
t a a a c a a g t t  g a a a a g c a a g  g g a c c t a g t a  c a g a g c c c t g  c g g t a c t c c a  
t g g t c c a a t t  a g a a a a t g t t  c c a t t t a c c a  c c a c t c t t t g  t a g t c t a t c t
t c t c t a t c c a  g g t a c a a a t a  c t a t g t t t c a  g g c c a a c a t t  c c t t a a t t t a  a c c a g t a a c c  
t t t t g t g t g g  c a c t g t a t c a  a a t g c t t t a g  c a a a g t c t a a  g t a a a t c a c a  t c c a c t g c c a
1 6 2 1
1 6 8 1
1 7 4 1
1 8 0 1
1 8 6 1
1 9 2 1
1 9 8 1
2 0 4 1
2101
2 1 6 1
2221
2 2 8 1
2 3 4 1
2 4 0 1
2 4 6 1
//
t c c c a g a a t a  
t g c a a t a t c a  
t c g t a a t t a a  
a a g t t g c a c g  
c a g t t c a a g t  
a c t t t t a c a c  
a a t t t t g a a a  
g c t c t t c c g c  
t g g c g g a g a c  
g t c c g c g g c a  
t t t g t t t g c g  
g c g a t c g t a c  
t g c c g g a g a g  
a a t a g c c c t t  
g a c a c a g c t t
t g a g g t c c c t  
c t g g a g t t c t  
a g c t g c a a c t  
c t t t g c a c c a  
t a a a t a a t g a  
a t a a a a a a t g  
g c c g a c a t a a  
a a a t c g g c t t  
g t c g a g g g c t  
g c t c g a a c t g  
t t g a a t c a g g  
g g t c g g a t t a  
a t c t g a c c t t  
t c a g t a g g g c  
c g g a g c g t c c
g c t c a c g t t c  
a g g a g a a g c t  
t t g t a g t g g c  
t g t t c c c a a t  
t a a a a t a c a t  
t a a a t a t c t c  
g a g a c a t t c c  
c c g c c a a c c c  
c g g t c a t g t g  
c a c a c c c a c t  
a g t c a g c g a g  
a a c c g g a g g g  
g c c a a c g a a t  
c c t c g g t t t c  
c t c c c c c a c t
t c a t a a a a a g  
t t g c a t t g t g  
c a a a a t g t c t  
a a t a c a t a a g  
t t c c c t g c t g  
a a c g t c a g a c  
c t a c t a c g t a  
c t c c c a c c g a  
c g a c t t t c c t  
c g g t g a c g c a  
t g a a c c g g g c  
a t t g c g t c g t  
c g t c t t t c g c  
t g c g t g c a t a  
c g t t t g g c
a a a t a t a t a t  
g g a a a t a a a g  
r a t a t g g a t t  
g t a a a t t g g a  
g g a g t g a g a g  
g g a g a g a c a a  
c c g g g c a a g a  
g a c c a g c a a a  
g a t t g g c t c c  
a g c a c t t t c t  
g a a a a a a a a g  
a a a a t a t t c c  
g t g t t c c c t g  
g g a c a a a a c c
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APPENDIX C 
PRIMARY TRANSGENIC EMBRYO DATA
52
Representative gels from PCR genotyping of transgenic embryos. Genomic DNA was isolated 
from individual embryos and amplified using GFP specific primters. The -480 bp band present in 
the above samples indicates a transgenic embryo. The lanes immediately to the left of the ladder 
are negative controls consisting of genomic DNA from an adult X. laevis.
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TABLE 2 
Summary of all transgenic experiments using truncated HIF-1 a promoter-GFP 
constructs.
Construct Name # Normal Embryos
# Exhibiting HIF-1a 
Fluorescence 
Pattern
Percentage 
Exhibiting HIF-1a 
Fluorescence 
Pattern
HIF(-1658)GFP 49 24 49.0%
HIF(-508)GFP 36 12 33.3%
HIF(-181)GFP 67 17 25.4%
HIF(UTR)GFP 49 7 14.3%
pEGFP-1 42 1 2.4%
TOTAL 243 61 25.1%
54
TABLE 3 
Summary of PCR genotyping experiments to determine if embryos contain a 
GFP transgene.
Construct Name # Fluorescent Embryos
# Non-fluorescent 
Embryos TOTAL
HIF(-1658)GFP 4 7 11
HIF(-508)GFP 4 5 9
HIF(-181)GFP 2 4 6
HIF(UTR)GFP 3 2 5
pEGFP-1 1 5 6
TOTAL 14 23 37
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TABLE 4 
Summary of PCR genotyping experiments to determine if those embryos 
exhibiting visual fluorescence contain a GFP transgene.
Construct Name Total # Fluorescent Embryos # Transgenic % Transgenic
HIF(-1658)GFP 4 4 100
HIF(-508)GFP 4 4 100
HIF(-181)GFP 2 2 100
HIF(UTR)GFP 3 3 100
pEGFP-1 1 1 100
TOTAL 14 14 100
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TABLE 5
Summary of PCR genotyping experiments to determine if those embryos not 
exhibiting visual fluorescence contain a GFP transgene
Construct Name Total # Non- fluorescent Embryos # Transgenic % Transgenic
HIF(-1658)GFP 7 5 71
HIF(-508)GFP 5 4 80
HIF(-181)GFP 4 3 75
HIF(UTR)GFP 2 2 100
pEGFP-1 5 3 60
TOTAL 23 17 74
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APPENDIX D 
EXPERIMENTAL PROTOCOLS
58
RNAse Protection Assay
(adapted from Sambrook and Russell, p. 7.65-7.74)
NOTE: Follow all guidelines for working with RNA (i.e. use plug tips, clean gloves, be extremely 
careful about contamination, etc.).
Probe Synthesis
1. Setup the following transcription reaction in an eppendorf tube at room temperature:
4.0 pi 5X transcription buffer
1.0 |liI nuclease-free H20
2.0 pi 0.1MDTT
4.0 pi ribonucleotides (mix equal amounts of rATP, rCTP, rGTP, and
sdd H20)
2.4 pi 100 pM rUTP
2.0 pi linearized DNA template
0.6 pi RNAse inhibitor
***behind shield from here on***
3.0 pi 32P-rUTP (30 pCi)
1.0 pi appropriate RNA polymerase
2. Mix reaction, spin down in picofuge, and incubate at 37°C for 45 minutes.
(NOTE: this is a good time to prepare the acrylamide gel you will need to run out your probe for 
purification. See end of protocol for recipe.)
3. Add an additional 1.0 pi RNA polymerase and incubate at 37°C for another 45 minutes.
4. Add 1.0 pi RQ1 DNAse. Mix well, spin one second in picofuge. Incubate at 37°C for 15 
minutes.
5. Add 10 pi RPA-formamide loading dye to reactions, boil 3 minutes to denature, and load on 
gel.
6. Run gel at 2000V until fast dye front is about 2/3 down the gel.
Probe Purification
(turn on 65°C water bath for elution after starting gel run)
1. Carry gel to dark room (305A) and separate with a licor wedge. REMEMBER ALARA - use 
the upper plate as a shield between you and the gel. Cover the gel completely with saran wrap.
2. Turn off lights and place a piece of film atop saran wrap and below the upper plate (crease 
one corner of the film for orientation purposes). Make sure to align the edges of the film with the 
edges of the bottom glass plate. Add some weight to the top plate and expose for 2 minutes.
3. Place the film in a lightsafe container (an old film bag works well) for transport to room 311. 
Develop the film following the machine instructions posted there.
4. Bring the film back to 305A and place film on bench over a piece of white paper. Place the 
plates over the film, aligning them in the same manner as step #2.
5. Gather the items you need for excising the bands and bring to room 305A: clean razor blades 
(for each band), DEPC water, geiger counter, and eppendorf tube containing 400 pi of elution 
buffer (for each band - recipe at end of protocol).
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6. Slide the top plate off the first band, pull saran wrap back, and cut the band out with a razor 
blade that has been washed with DEPC water. Place the band in the eppendorf tube containing 
elution buffer. REMEMBER ALARA!
7. Transport the tubes containing bands back to room 301 and vortex vigorously. Make sure the 
bands are immersed in the buffer and incubate in the 65°C water bath for 3-4 hours.
8. Following elution, transfer eluates to a new labeled eppendorf tube after spinning down briefly 
in the microfuge to gather gel at the bottom of the tube.
9. Remove 1 pi of eluate and count in the liquid scintillation counter.
10. Add 1 ml cold, 100% ethanol to eluate ubes and place in -80°C on dry ice until solid. (For a 3 
day assay, you can stop here if needed) -  Turn water bath to 50°C
11. Spin at 4°C for 20 minutes to pellet labeled probe. Remove supernatant to an eppendorf 
tube and discard in solid radioactive waste (take care to keep appropriate records). Invert tubes 
on a pad of paper towels and allow to dry 5 minutes. -  Turn a heat block to 85°C
12. Resuspend pellets in an amount of hybridization solution (recipe at end of protocol) that will 
bring probe to around 100K cpm / pi. (For example: if you had 200K cpm before precipitation, 
use 500 pi of hybridization solution to halve per pi cpm). Remove 1 pi of this final probe solution 
and count in liquid scintillation counter. If needed, you may add more hybridization solution to 
bring counts down and recount.
Hybridization Reactions
1. Thaw RNA on ice and aliquot X pL of RNA into eppendorf tubes labeled for each hybridization, 
(check with MSS for RNA mass and volume you should use!)
2. Dry RNA in the speed-vac until supernatant is nearly all gone (~1 pi liquid left). DON’T 
OVERDRY!
Each hybridization reaction should be 20 pi in volume. You want to add appropriate amount of 
probe (usually 50-100K cpm - check with MSS!) and enough hybridization solution to bring to 20 
pL volume. Use scintillation counts from step #12 above to calculate volume of each needed.
3. Add appropriate amount of hybridization solution to dried-down RNA. It is important to 
ensure that all RNA is dissolved in hybridization solution. Make sure to wash hybridization 
solution over the sides of tube multiple times and vortex each tube vigorously for at least 20 
seconds.
4. Add appropriate amount of probe to each reaction and mix well. Spin down in picofuge and 
denature in 85°C heating block for 10 minutes. Save probes overnight by placing in a shielded 
container in -20°C.
5. Take the entire heating block to 50°C water bath and transfer tubes to bath directly.
6. Allow probe to hybridize overnight (or for at least 10 hours).
Digestion Reactions
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1. Set heat block to 50°C and transfer eppendorf tubes to it. Add 350 pi digestion buffer (recipe 
at end of protocol) to each sample (in room 305 behind shield, and still in heat block -- this 
assures RNase digestion at prescribed stringency).
2. Flick mix and transfer each tube to 37°C (also behind shield). Incubate for 30 minutes. -  
Thaw proteinase K (10 mg/mL) and tRNA (5 mg/mL) on ice (both in -20°C freezer in 301)
3. Pour acrylamide gel (recipe at end of protocol) using white, narrow sharkstooth comb inserted 
to form wells.
4. Stop RNA digestion by adding 20 pi of 10% SDS followed by 10 pi of proteinase K (10 
mg/mL), mix and incubate for 15 minutes at 37°C in heating block.
5. Add 400 pi of P/C to each sample, vortex or shake well, and spin for 5 minutes in centrifuge 
behind shield.
6. During spin, add 5 pi of carrier tRNA (5 mg/mL) to new labeled eppendorf tubes. Transfer the 
aqueous phase of extraction to these tubes and mix well.
7. Add 1 ml cold, 100% ethanol and place in -80°C freezer on dry ice until solid.
8. Spin at 4°C for 20 minutes. Remove supernatant from each sample to radioactive waste by 
pouring. -  begin water bath boiling
9. Use a pipette tip to completely remove any remaining supernatant. Dry in speedvac for 3-5 
minutes until just dry. -  prepare gel for running (prepare comb, assemble apparatus, fill with 
buffer)
Running Samples
1. Resuspend samples in 2 pi of TE and 2 plof RPA-formamide dye. Vortex each sample for 20 
seconds to ensure complete resuspension.
2. Prepare ‘probe only’ samples. To 4 pi of RPA-formamide dye add a volume of probe 
containing around 10K cpm.
3. Place all samples in plastic racks in boiling water bath to denature.
4. Ensure integrity of gel by adding a few microliters of RPA dye to each well. Avoid wells that
are clogged or leaking in the final load.
5. Bring samples over to picofuge 3 at a time, spin down briefly, and load into wells. When there
are ~6 samples left, turn off hot plate, and add ladder to water bath for denaturation.
6. Load all samples, then the probe only controls, and finally the ladder onto the gel.
7. Run the gel until the slow dye front is ~8 inches from the bottom of the plate (usually between 
1.5-2 hours). Ask MSS how long to run gel as it will vary from assay to assay.
8. Carefully separate plates with licor wedge and apply 3MM paper to the gel. Smooth the paper 
over the gel and give it a minute to affix completely. Peel the paper up, cover the gel with saran 
wrap, and place on the gel dryer for 2-2.5 hours at 78°C
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9. Remove saran wrap. Carry to dark room and load into cassette - gel, film, intensifying screen. 
Place in -80°C freezer for 6 hours - 2 weeks depending on nature of the expression (ask MSS for 
advice!).
RPA Recipes
Elution Buffer: (10 ml)
667 pi 7.5M AmOAc 
1000 pi i0% SDS 
20 pi 0.5M EDTA (pH 8.0) 
bring to 10 ml with SDD H20
Hybrization Buffer: (5 ml)
4 ml deionized formamide 
400 p.l 5M NaCI 
400 p.l 0.5M PIPES 
10 p.l 0.5MEDTA 
190 p.l SDDH20 
store at -20DC
6% Acrylamide Gel
46 g urea 
40 ml SDD H20 
15 ml 40% acrylamide
5 ml 10XTBE
RUNNING BUFFER: 0.5X TBE
1. Combine ingredients in 250 ml beaker and stir on lowest heat with foil covering top (turn heat 
off after a few minutes of stirring)
2. Clean glass plates well with DEPC H20 and isopropanol.
3. Prepare 10% APS solution (1ml SDD H20 and 0.1 g ammonium persulfate).
4. Assemble plates together with spacers in between and cover 3 sides with yellow sequencing 
tape.
5. Add 700 pi 10% APS and 18 pi TEMED, stir briefly, and pour gel.
NOTE: the probe purification gel uses the large wells, whereas the final RPA gel uses the white 
sharkstooth comb.
RPA-formamide loading dye:
800 pi deionized formamide
20 p.l 0.5M EDTA
90 p.l xylene cyanol (10mg/ml)
90 p.l bromphenol blue (10mg/ml) 
Store at 4°C
Digestion Mix: (10 ml)
100 p.l 1.0MTRIS, pH 7.6 
100 p.l 0.5M EDTA pH 8.0 
600 p.l 5M NaCI 
40 p.l RNAse A (10 mg/ml)
1.4 p.l RNAse T (100,000 U/ml) 
bring to 10 ml with SDD H20
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General Cell Culture Methods
In order to keep cell health at a maximum, flasks of cells must be cared for on a routine basis. 
Fresh culture media must be added every 3-4 days, and when cells approach confluency, they 
must be split into several flasks to maintain exponential growth. It is important to maintain aseptic 
technique whenever working with cells (sterilize everything with 70% ethanol prior to using, never 
open reagents outside of hood, clean up spills immediately, turn UV light in hood on when done, 
etc.)
Made culture media for Xenopus A6 cells consists of: 75% NCTC-109, 15% SDD H20, and 10% 
heat-inactivated fetal bovine serum. Penicillin (100U / ml) and streptomycin (100 pg / ml) may 
also be added to control bacterial growth. To make a fresh bottle of made media, add the 
following to an unopened 100 ml bottle of NCTC-109: 18 ml SDD H20, 12 ml FBS, and 1.2 ml of 
pen/strep solution (10,000 U / ml).
A. Changing into fresh media (“feeding the cells”)
To change out culture media, simply draw off the “old” media in the flask being careful to avoid 
disturb the cell monolayer. Discard this supernatant into an appropriate waste container 
containing a bleach solution. Add fresh culture media to the container (7 ml for a T25 flask, 5 ml 
for a 60mm dish) and place in incubator.
B. dPBS
It is important to never wash cell cultures with pure water, instead Dulbecco’s phosphate buffered 
saline is used (examine chemical bottle carefully, there are two forms of sodium / potassium 
phosphate!). For a 500 ml volume: 0.10 g KCI
0.10 g KH2HP04
4.00 g NaCI
1.08 g Na2HP04 * 7 H20  
Add the solids to a bottle, bring up to 500 ml with TC water, and autoclave. After the bottle has 
cooled slightly, close the cap completely and do not open it until inside the hood under sterile 
conditions. Aliquot into 50 ml falcon tubes for use.
C. Subculturing (“splitting cells”)
This process will digest the cell monolayer off the bottom of the flask for dispersal into new flasks 
at a lower titer. You will need to set a heating block at 37°C and prewarm an eppendorf of 2.5% 
trypsin solution (in 316 freezer) and bottle of culture media (316 fridge) in the incubator.
1. The working concentration of trypsin is 0.25%. In a 15 ml falcon tube, add 1.0 ml of 2.5% 
trypsin to 9 ml of dPBS and mix well.
2. Pipette off the media from the flask you wish to split and discard into appropriate biowaste 
container.
3. Add ~7 ml of dPBS to the flask to wash the residual culture and dead cells away. Gently 
swish the dPBS around in the flask for a few moments and pipette off into biowaste.
4. Add approximately 2 ml of 0.25% trypsin solution to the flask. Make sure the solution covers 
the entire flask surface.
5. Incubate the flask at 37°C for 2-3 minutes to separate the cells from the flask. You will be 
able to see this process macroscopically, but it is helpful to look under the microscope to see 
the cells “ball up” and come off the bottom of the flask.
You will need to titer your cells according to how you will use them. A good ratio for 
housekeeping subculture is 1:4, meaning you would split the cells into 4 separate flasks. There is 
no need to remove the trypsin solution, as the culture media will inactivate it.
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6. Mix the cells vigorously by pipetting up and down to break up cell clumps and evenly disperse 
them. Pipette equal amounts of culture into new flasks (make sure that the cells are well 
suspended when doing this to make sure each flask gets an equal number of cells).
7. Bring the new cultures up to final volume by adding 7 ml of made culture media and place in 
the incubator. The cells will settle and reattach overnight.
D. Freezing cells for long-term storage
This procedure is used to store cells over breaks or for other periods of time where routine care is
not possible.
1. Trypsinize the cells and add 8 ml of made culture medium. Transfer the cells to a sterile 
falcon tube.
2. Centrifuge gently (125 x g) for 3 minutes at room temp and remove supernatant into
biowaste. Wipe down the outside of the tube with 70% ethanol before returning it to the
hood.
3. Mix cell culture freezing medium (Invitrogen) well by inversion of thawed tube. Gently
resuspend the cells in 2 ml of cell culture freezing medium by pipetting up and down carefully.
4. Centrifuge for 1 minute at 125 x g and remove supernatant to biowaste.
5. Resuspend the cells in 2 ml of cell culture freezing medium.
6. Aliquot 1 ml into each of two cryotubes.
7. Freeze slowly at -80°C in a heavily insulated styrofoam container overnight. Place cells in 
long term storage container.
E. Reviving cells
1. Remove cells from freezer and thaw rapidly by agitation in a 37°C waterbath (40-60 
seconds).
2. After rinsing tube with 70% ethanol, return to the hood and add cells dropwise to fresh made 
culture medium in a flask.
3. Incubate at 37°C until cells attach to flask and then change medium to remove trace amounts 
of DMSO.
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GFP Fluorescence and B-Galactosidase Assay of Transfected
Cells
(from Promega protocol)
Cell Lysate Preparation
1. Add 4 volumes of water to 1 volume of 5X reporter lysis buffer (RLB -  from Promega kit) to 
produce a 1X stock solution.
2. Remove the growth medium from the cells to be assayed into a 15 ml falcon tube. Add 1 ml
0.025% trypsin solution to the plate and incubate at 37°C for 2 minutes.
3. Wash the solution over the plate to resuspend all cells off the bottom of the plate. Withdraw 
the trypsin and add it to the falcon tube containing the media from step 2.
4. Wash the plate with 1 ml of dPBS and add to the falcon tube.
5. Spin the falcon tube at 750 x g for 5 minutes to pellet cells. Withdraw all but ~200 pi of the 
supernatant to liquid waste.
6. Resuspend the cell pellet in the remaining supernatant and transfer to an eppendorf tube. 
Spin the cells for 5 minutes at 750 x g to pellet.
7. Pipet off the supernatant to liquid waste. Add 500 pi of dPBS to the pellet and resuspend by 
pipetting up and down. Spin the cells for 5 minutes at 750 x g.
8. Remove all dPBS from the pellet and add 60 pi of 1X RLB. Resuspend the pellet by 
vortexing vigorously. Sonicate the cells for 10 seconds on the ‘4’ setting.
9. Spin tubes in the picofuge to determine if complete lysis has occurred. If not, sonicate the 
cells for a further 10 seconds. Repeat this step until lysis is complete.
GFP Activity Assay
NOTE: It is necessary to let the fluorometer warm up for 30 minutes to obtain accurate readings.
1. Fill the fluorometer cuvette with 60 pi of 1X RLB and place in the machine. Set the gain to 
HIGH and ZERO the machine until it holds steady at ±5.
2. Withdraw 1X RLB from the cuvette and discard. Place 60 pi of test sample into the cuvette. 
Ensure that no air bubbles are visible in the windows of the cuvette as this will interfere with 
the light path. Place the cuvette into the fluorometer and allow reading to steady before 
recording.
3. Withdraw test sample back to eppendorf tube to save for p-gal assay.
4. Wash the cuvette twice with 100 pi of 1X RLB to remove any residual fluorescence before 
placing new sample in the cuvette. Repeat steps 2-4 for each sample.
p-Galactosidase Assay
1. Thaw 2X assay buffer. If the solution has precipitate, warm at 37°C briefly to dissolve.
2. Dilute the cell lysate with 90 pi of 1X RLB.
3. Add 150 pi of Assay 2X buffer to each tube and mix well by vortexing.
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4. Incubate the reactions at 37°C overnight.
5. The following day, stop the reactions by adding 250 i^l of 1M Sodium Carbonate. Mix by 
shaking briefly.
6. IMMEDIATELY read the entire sample’s absorbance at 420 nm on a spectrophotometer to 
obtain a value for p-galactosidase activity.
Transgenic Sperm Nuclei Preparation
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These solutions need to be made up prior to beginning the procedure:
30ml 2X NPB (Make up fresh) Final Cone. In 1X
10ml 1.5M sucrose 250mM
900pl 1.0M HEPES 15mM
120gl 0.5M EDTA 1.0mM
300pl 0.1M spermidine 0.5mM
120|jl 0.1M spermine 0.2mM
60.8pl 1.0M DTT 1.0mM
Bring up to 30 mi with SDDH20.
Make 40mls of 1xNPB (for testis washes and spins)
10ml 1XNPB + 3%BSA
5 ml 2X NPB
2 ml sddH20
3 ml 10%BSA
10mls 1XNPB +0.3%BSA
2.5ml 2x NPB 
2.35ml SDDH20 
150|jI 10%BSA
1ml Storage Buffer
500|jl 2X NPB 
300pl glycerol 
170pl dH20 
30pl 10%BSA
Sperm Dilution Buffer
3.34 ml 1.5M Sucrose 
1.5ml 1.0MKCL 
1 OOjjI 0.1M spermidine 
40|jl 0.1M spermine
80pl 0.1N NaOH (should bring to pH 7.3-7.5)
14.94mldH20
store at -20°C in 0.5ml aliquots.
1. Remove testes from a male and rinse 3X in cold 1xMMR and 2x in 1xNPB in petri dishes. 
With forceps remove as much fat tissue and blood vessels as possible.
2. In a dry petri dish, add a few drops of 1X NPB and homogenize testes with forceps.
3. Resuspend homogenate in 8 ml cold 1X NPB and filter through Nitex mesh (100um) into a 15 
ml corex tube.
4. Spin at 3000 RPM for 10 minutes at 4°C in Sorvall HB-4 rotor.
5. Set up Percoll step gradient in a 15 ml corex tube, bottom: 4ml 50% Percoll in 1X NPB; 
middle: 4ml 24% Percoll in 1X NPB.
6. Gently resuspend the sperm pellet in 3ml 1X NPB. Carefully layer this solution on top of the 
Percoll gradient.
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7. Spin at 3000 RPM for 15 minutes at 4°C in Sorvall HEM rotor. This step removes inviable 
sperm.
8. Remove as much Percoll as possible by pipetting, and carefully resuspend sperm pellet in 
8ml cold 1X NPB.
9. Spin at 3000 RPM for 10 minutes at 4°C in Sorvall HB-4 rotor to wash out any residual 
Percoll.
10. Resuspend sperm pellet in 1ml of room temp 1X NPB. Add 5pl 10mg/ml digitonin (stock 
10mg/ml in DMSO stored at-20C). Incubate at room temp for 5 minutes.
11. Add 10ml cold NPB with 3% BSA (no inhibitors) and spin at 3000 RPM for 10 minutes at 4°C 
in Sorvall HB-4 rotor.
12. Carefully resuspend pellet in 5mls cold 1X NPB with 0.3%BSA and spin as above.
13. Carefully resuspend sperm nuclei in 100-500ul (depending on concentration) in sperm 
storage buffer.
14. Count sperm nuclei using hemocytometer. Dilute sperm stock 1:100 in sperm dilution buffer 
and add 1 ul of 1:100 Hoechst stain stock to dye DNA. Follow hemocytometer counting 
guidelines to determine the number of sperm / nl.
Sperm nuclei can be used 2-3 days if stored at 4°C. For long term storage of sperm nuclei, snap
freeze in liquid nitrogen. On injection day, thaw an aliquot on ice to use in transgenic reaction.
Preparation of High Speed Egg Extract
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Solutions for Preparations of High-Speed Egg Extracts: (make these up before beginning the 
procedure)
2.5M KCI (186.4g in 1L SDD H20)
0.5M MgCI2 (10.165g in 100ml SDD H20)
1M CaCI2 (14.702g in 100ml SDD H20  -  filter sterilize and store at 4°C)
1.5M Sucrose (51,35g in 100ml SDD H20  -  filter sterilize and store at 4°C)
5M NaCI (146.1g in 500ml SDD H20)
1M HEPES (26.03g in 100ml SDD H20  -  titrate to pH of 7.7 with 10N KOH)
0.1M EGTA (0.384g in 10ml SDD H20)
20X Extract Buffer Salt Stock (1L)
800ml 2.5M KCI
40ml 0.5M MgCI2
2ml 1MCaCI2
sddH20 to 1L
Filter sterilize and store at 4°C.
10X MMR (1L) Final Cone.
200ml 5M NaCI 1M
8ml 2.5M Kcl 20mM
20ml 0.5M MgCI2 10mM
20ml 1MCaCI2 20mM
50ml 1M HEPES 50mM
SDD H20  to 1L and autoclave
1X MMR (2.5L) Final Cone.
50ml 5M NaCI 100mM
1ml 5MKCI 2mM
5ml 0.5M MgCI2 1mM
5ml 1MCaCI2 2mM
12.5ml 1M HEPES 5mM
SDD H20  to 2.5L and autoclave
1XXB Salts (2L)
100ml 20XXB Stock 
SDD H20  to 2L
Extract Buffer (XB) (500ml) Final Cone.
16.66ml 1.5M Sucrose 50mM
25ml 20XEB Stock 1X
0.5ml 1M HEPES* 10mM
SDD H20  to 500ml
CSF-XB (100ml) Final Cone.
5ml 20X Salts 1X
200pl 0.5M MgCI2 1mM
1ml 1M HEPES 10mM
3.33ml 1.5M Sucrose 50mM
5ml 0.1MEGTA 5mM
SDD H20  to 100ml
Final Cone. 
2M
20mM
2mM
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Energy Mix (1ml)
0.049g creatine phosphate
0.012g ATP
40pl MgCI2
SDD H20  to 1ml
store @ -20°C in 100pl aliquots
Final Cone. 
150mM 
20mM 
20mM
2% (w/v) cysteine in 1x XB Salts
Prepare ~600ml within 1 hour of use and titrate to pH 7.8 w/ NaOH.
It is extremely important to prepare all solutions before beginning the next section of the protocol 
as it is time sensitive.
1. To prime the frogs for ovulation, inject 12 female adult Xenopus frogs with 50 units of HCG 
into the dorsal lymph sac. Maintain the frogs at room temperature for 24 hours.
2. The day before the extract preparation begins, inject each frog with 800 units of HCG. 
Maintain each frog in its own container with 4 liters of dechlorinated water.
3. Place the frogs at 15-18°C overnight.
4. The next morning, pool all laid eggs in 1X MMR. Discard any batch that contains noticeably 
mottled, lysing, or dying cells. In addition, manually expel eggs from each frog and pool into 
the large egg batch.
NOTE: It is important to have LARGE numbers of eggs (enough to fill 3 Beckman tubes to 
the top after dejellying). Therefore, multiple batches of squeezing eggs may be 
required.. .store eggs in High Salt MBS at 18°C until obtaining enough eggs.
Carry out the following procedures promptly through all steps once initiated. Optimally, begin the 
high-speed spin within 60 minutes of dejellying the eggs.
5. Remove as much 1X MMR as possible from the eggs and dejelly in 1X XB Salts, containing 
2% cysteine. Add a small amount of cysteine and swirl the eggs. Partially replace with fresh 
cysteine several times during the dejellying process.
6. Wash eggs four times in 100ml of Extract Buffer and then twice in 50ml of CSF-XB containing
1x protease inhibitors.
Note: Completely cover the eggs with solution during each wash.
7. Use a wide-bore Pasteur pipette to transfer eggs to a 14x95mm Beckman ultraclear tubes 
(Beckman 344060).
Note: These tubes hold about 10ml of solution. You need at least three tubes at this point! 
Try to transfer an equal volume of eggs to each tube. Uneven loading at this stage can make 
balancing the tubes very difficult later on.
8. Remove as much CSF-XB as possible from each tube and pack the eggs in a clinical 
centrifuge. Spin for about 60 seconds at 1000rpm (150g) and then an additional 30 seconds 
at 2000rpm (600g)
9. Remove excess CSF-XB and balance the tubes as well as possible without disturbing the 
packed eggs.
10. Centrifuge at 10,000 RPM for 10 minutes at 2°C in the ultracentrifuge SW4Ti swinging bucket 
rotor.
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Note: This treatment should crush the eggs, which will then separate into three distinct layers: 
lipid (top), cytoplasm (center), and yolk (bottom).
11. Remove tubes from centrifuge jackets and insert an 18-guage needle through the wall of the 
centrifuge tube at the base of the cytoplasmic layer. Slowly draw out the cytoplasm and 
transfer the cytoplasm to a fresh Beckman ultraclear tube on ice.
12. Estimate the volume of extract and add a 1:1000 dilution of protease inhibitor stock solution 
to the isolated cytoplasm.
13. Recentrifuge the cytoplasm in polypropylene tube for an additional 10 minutes at 10,000 
RPM to clarify, again using the SW4Ti swinging bucket rotor. Collect the clarified cytoplasm 
as in step 13.
14. Measure the exact volume of the cytoplasm obtained and add 0.05 volume Energy Mix (~175 
pi). Transfer the mixture to a 3ml thick-walled polycarbonate ultracentrifuge tube (Beckman 
#355870 for use with Beckman SW4Ti rotor).
Note: It is critical that each tube is at least half full or it will collapse in the centrifuge.
15. Add CaCI2 to a final concentration of 0.4mM (-1.4 pi 1M CaCI2).
Note: This inactivates CSF and pushes the egg extract into interphase.
16. Incubate for 15 minutes at room temperature. Balance the tubes carefully and place in 
SW4Ti rotor with the rubber adaptor for small tubes in place. Centrifuge at 200,000 x g (this 
is -38,000 RPM in ultracentrifuge using SW4Ti rotor) for 1.5 hours at 4°C.
Note: The cytoplasm will fractionate into four layers, top to bottom: lipid, cytosol, 
membranes/mitochondria, and glycogen/ribosomes.
17. Insert a 17 or 18-guage needle into the top of the tube, through the lipid layer, and remove 
the cytosolic layer from each tube (-30-50% total volume). Transfer this fraction to fresh 
ultracentrifuge tubes.
NOTE: It may be necessary to collapse the number of tubes down at this point to maintain a 
concentrated extract.
18. Repeat centrifugation at 200,000 x g for 20 minutes at 4°C.
19. Transfer the final supernatant to 0.5ml microcentrifuge tubes in 20ul aliquots. Snap freeze 
aliquots in liquid nitrogen and store at-80°C.
20. The quality of egg extract should be tested for activity by combining it with sperm nuclei at 
room temperature. If extract is active, sperm nuclei should swell visibly when visualized 
under a microscope (thicken and lengthen) within 10 minutes.
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Transgenic Procedure
You will want to prepare the following before the actual transgenic day:
1. Siliconize needles. Do this before you actually pull the needles. Attach a small piece of 
Tygon tubing to the end of a capillary (Harvard Apparatus). A pipette tip can now fit into the other 
end of the tubing. Backfill the needle with Sigmacote until several drops come out of the bottom. 
Withdraw most of the solution by releasing the plunger of the pipet. Quickly rinse by backfilling 
the needle twice with 200 fl of SDD water.
2. Make needles. Use the vertical needle puller set to 48, 690 (no weights). Once the needle is 
pulled, you will need to break it at so the bore is 60-80 fm (check size with a microscope and a
0.01.fm slide). Ideally, the needle should have a taper of 12-15mm with a beveled tip. Do this by 
clipping the tip with tweezers held at a 45 degree angle to the appropriate length.
3. Prepare pump. It is necessary to fill the entire tube and syringe with mineral oil, but bubbles in 
any part of the system will interfere with the flow. Routine fills can be performed using the 
following procedure:
a. Detach end of tubing from injection apparatus.
b. Fill the plastic collar with mineral oil using a pipet. Make sure that you do not introduce
air bubbles into the collar or tubing. Place the end of the tubing below the 
surface of the oil
c. Gently pull back on the plunger (while keeping end in the mineral oil) to refill the tube
and syringe.
d. Use a pipet to add an excess amount of mineral oil to the joint where the tube will be
reattached and hook the tubing back up to injection apparatus.
4. Make injection dishes. (2.5% molecular grade agarose in 0.1x MMR)
For 100mls (makes 6-8 dishes):
2.5g agarose 
100ml 0.1x MMR
Completely melt in microwave for ~2 min. Pour into 60mm Falcon dishes until liquid is ~0.5 cm 
from the top edge. Make injection depressions by placing a small hexagonal weigh boat on the 
surface of the agarose before it hardens (ensure there are no air bubbles underneath). Wrap 
dishes in parafilm and store at 4°C.
5. Quantify plasmid DNA. Use the GeneQuant machine located in the Bradley lab to determine 
the concentration of your linearized plasmid DNA. The concentration of DNA added to a 
transgenic reaction should be ~150-200 ng/fl.
6. Prepare solutions. You will need 1X MMR, 0.4X MMR containing 6% Ficoll, 0.1X MMR 
containing 6% Ficoll, and 0.1X MMR.
The following procedure is extremely time intensive. Make plans to begin early in the morning 
and have most of the day free for sorting.
1. Inject frogs (usually 2 to ensure eggs) with 800 units HCG the night before.
2. Fresh oocytes are collected from the female frog by squeezing. Dejelly in 2.3% cysteine (pH 
7.8-8.0) for no more than 5 minutes. Wash in 1X MMR and then transfer to injection dishes 
filled with 0.4X MMR and 6% Ficoll.
2. Thaw sperm nuclei and sperm dilution buffer on ice. Heat treat egg extract (straight out of the 
freezer) at 85°C for 8 minutes. Following this incubation, spin at max speed in microcentrifuge 
tube for 5 minutes.
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3. While spinning egg extract, combine 1pl of sperm nuclei with 5pl of plasmid DNA. Incubate at 
room temperature for 5 minutes.
4. To the DNA/sperm nuclei mix add 10(jl heat-treated egg extract, 0.5pl Notl (1:20 dilution in sdd
water) and 2.4pl 100mM MgCI2. Gently mix by pipetting through a cut-off pipette tip. Do not
mix vigorously and try to avoid introducing bubbles to the solution as the nuclei are very 
delicate. Incubate at room temperature for 10-12 minutes.
5. After this incubation, dilute the sperm with 400 pi sperm dilution buffer and 26 pi 100mM
MgCI2. Backfill a siliconized needle by attaching a small piece of Tygon tubing to the back 
end of the injection needle. Insert a pipette tip into the tubing and fill the needle with the 
diluted, transgenic sperm nuclei. Remove the tubing and attach needle to microinjector.
6. Turn pump on and set to 9.0pl/ min. This is to make sure that there is no blockage, and you 
should see a drop form at the end of the needle. Quickly turn the pump off after seeing that 
the needle is clear.
7. Set the pump to 0.6 pl/min. Place tip of needle into MMR/Ficoll solution (you will be able to 
see oil swirls in the Ficoll solution if the needle is flowing).
8. Inject each egg at a 90 degree angle to its surface with a quick piercing motion. After a few 
minutes, the pigment of injected eggs will contract (this is a good indicator of the injection 
status of each egg). The nuclei are only stable for < 30 minutes, so you want to move quickly.
9. Following injection, place at 18°C for ~2-3 hours. During this time, the first cell divisions will 
occur.
10.Sort the eggs in dishes, separating out the cleaving eggs. Place these in 0.1 X MMR with 6% 
Ficoll overnight.
NOTE: Save the “bad’1 eggs until the end o f sorting so that you can go back and do a quick 
second sort for eggs you may have missed or were slow to develop. After this last sort, 
dispose of the eggs. If they haven’t cleaved by now, they aren’t going to!
11.The following morning during gastrulation, transfer embryos to 0.1 X MMR and allow to 
develop until desired stage.
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Densitometric RPA Gel Analysis using ImageQuant 5.0
(See ImageQuant 5.0 User’s Guide for more details)
Before starting, read the ImageQuant manual as it has a lot of information about image analysis
and background subtraction so you will know how to analyze your images correctly.
A. Image Acquisition
1. Scan the RPA film in on the HP 4470c scanner using the HP PrecisionScan software with the 
auto-resolution feature turned on. Save the scanned image as an 8-bit grayscale TIFF file.
B. Optimizing Image View and Marking ROIs for Analysis
1. Open the TIFF image in ImageQuant.
2. Open the Gray/Color Adjust window. The histogram plot in the Histogram area of the window 
contains a statistical view of the image data. Modify the high and low values in the histogram 
window to achieve maximal contrast and brightness and click the OK button. This will not 
modify your data, it is only for viewing purposes.
3. To outline a region of interest, use the rectangular selection tool to draw a box around a band 
of interest. Try to narrow the box to include only the band in which you are interested. Avoid 
including background in the rectangle.
4. After you have outlined the first band, you can use it as a ‘stamp’ to outline other bands of 
interest. Click and hold the mouse button to drag the rectangle until it is over the next band 
of interest and press the V  key. This will imprint this rectangle on your image.
5. Enclose each band of interest in a rectangle. Make sure that each rectangle is the same 
size!
C. Analyzing Lanes and Obtaining Values
1. Click and hold the mouse to drag a rectangle over your bands of interest. This will select 
your objects for analysis.
2. Set the Background Correction method from the Preferences menu. Choose which 
background method you want to use (see manual for detailed description of each). For RPA, 
drawing an additional rectangle around blank space to give a background reading works well. 
In this case, select the Object Average button and, in the pull down box, choose the rectangle 
number that represents background. Press the Set button to apply this method to all chosen 
objects.
3. From the Analysis menu choose Volume Report and press the Report button to generate 
values for each object.
4. A window will come up showing the values obtained for each object. The Volume 
measurement is the value that corresponds directly to the intensity of the band. If you close 
the report, ImageQuant will ask if you would like to transfer your data to Microsoft Excel to 
save it as a spreadsheet.
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